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From a certain point onward there is no longer any turning back. 
That is the point that must be reached. 
 
Franz Kafka 
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SUMMARY OF PAPERS I-III 
 
Paper I reports the results from a long-term (29 months) follow-up of a randomised, 
controlled trial (RCT) evaluating the effect of exercise therapy and patient education by 
outcome measures of specific impairments and activity limitations in patients with hip 
osteoarthritis (OA). One hundred and nine patients with radiographic and clinical hip OA, 
considered to have mild to moderate symptoms, were included. The mean age of the 
included patients was 57.8 years, and 54 % were women. Patients with knee pain/knee 
OA, back pain or specific comorbidities were excluded form participation. Patients were 
randomised to receive either 1) a patient education program followed by a 12 week 
exercise therapy program and (exercise therapy group) or 2) a patient education 
program only (control group). Assessments were conducted four, ten and 29 months 
after enrolment, and included hip range of motion (ROM), isokinetic concentric knee and 
hip flexion and extension muscle strength, the six minute walk test for distance (6MWT) 
and pain during walking assessed by a visual analogue scale (VAS) for pain. At the 29-
month follow-up 10 % of the patients were lost to follow-up, 25 % had undergone total 
hip replacement (THR) surgery and did not participate at subsequent follow-ups, and 3 % 
did not complete the clinical/functional tests. Fifty three percent of the patients in the 
exercise therapy group were compliant to the program, defined as participating in 80 % 
of the exercise sessions. The results revealed that the exercise therapy group reported 
significantly less pain during walking over the 29 month follow-up (p=0.018), but no 
group differences were shown for ROM, muscle strength or walking capacity assessed by 
the 6MWT.  
 
In Paper II we conducted a long-term follow-up of the 109 patients in the RCT to compare 
the 6-year survival of the native hip to THR between patients who were given exercise 
therapy and patient education and patients who were given patient education only. 
Additionally, we evaluated the treatment effect on self-reported pain, stiffness and 
physical function by using the Western Ontario and McMasters Osteoarthritis Index 3.1TM 
(WOMAC). Main outcome measure for this long-term follow-up was survival of the native 
hip to THR. Thus, 3.6-6.1 years after inclusion, in May 2011, we assessed whether and 
when patients had gone through THR. The WOMAC was used at the four, ten, 16 and 29 
months follow-up, and was included as an outcome measure in order to compare levels of 
pain, stiffness and physical function between the exercise therapy group and the control 
group prior to THR or end of study. The response rate at the 3.6-6.1 years follow-up was 
94 %. Patients who were lost to follow-up were treated as censored in the analyses. The 
6-year survival of the native hip to THR was significantly higher in the exercise therapy 
group compared to the control group. The Hazard rate in the exercise therapy group 
compared to the control group was 0.56, indicating that the 6-year risk for THR was 
reduced by 44 % in the exercise therapy group. Furthermore, we found that the exercise 
group had significantly better self-reported physical function over the 29 months period 
compared to the control group (p<0.01). However, no group-differences were revealed 
for self-reported pain (p=0.083) or stiffness (p=0.112).  
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In Paper III we evaluated the reliability and validity of the Physical Activity Scale for the 
Elderly (PASE) for this hip OA patient population with mild to moderate symptoms. Forty 
patients with a mean age of 61.3 ±10.0 years (50 % women) were recruited from the RCT 
and included in the study. The test-retest reliability was examined by both relative and 
absolute measures of reliability. The construct validity was studied by comparing the 
PASE to both an accelerometer and the International Physical Activity Questionnaire 
short form (IPAQ). The test-retest reliability of the total PASE score was considered to be 
moderate, with an acceptable intraclass correlation coefficient (ICC) of 0.77, but with 
relatively large measurement error. The calculated minimal detectable change (MDC) was 
87, implying a change in PASE score larger than 87 points to be considered to represent a 
real change. The correlation coefficient between the total PASE score and the categories 
representing total physical activity level of the IPAQ and the accelerometer recordings 
was 0.61 and 0.30, respectively. The correlation coefficients were in line with the a priory 
hypotheses. However, the correlation coefficient between the PASE and the 
accelerometer did not exceed 0.5, which has been defined as the cut-off for acceptable 
construct validity. In addition, we found that the specific items addressing light, moderate 
and vigorous physical activity to be of poor validity and test-retest reliability. 
Hence, the PASE was found inadequate to provide valid data on physical activity level and 
intensity in patients with mild to moderate hip OA. 
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PREFACE 
 
Exercise therapy is recommended to be offered to all individuals with OA of the hip or 
knee as a first line treatment. These recommendations are based on the evidential 
beneficial effect of exercise on self-reported pain and function in RCTs including patients 
with knee OA. However, guidelines based on the aggregated effect for hip and knee OA 
may be inappropriate, as the exercise effect and the underlying mechanisms may differ 
between the two joints. Previous studies suggest that exercise therapy may improve self-
perceived pain and function in patients with hip OA, but evidence is limited due to few 
available RCTs including patients with hip OA only. Furthermore, knowledge is sparse 
regarding the long-term effect of exercise interventions. Thus, the need for high-quality 
research investigating the effect of exercise therapy in patients with isolated hip OA is 
highly emphasised. 
 
To address this lack of evidence the Norwegian research center for Active Rehabilitation 
(NAR) launched an RCT in 2005 to evaluate the effect of exercise therapy and patient 
education in patients with hip OA. The study was initiated by Professor, Physical 
Therapist (PT), PhD May Arna Risberg, Professor, Medical Doctor (MD), PhD Lars 
Nordsletten, PT, PhD Kjersti Storheim and PT, PhD Linda Fernandes, as a collaboration 
between Ullevål University Hospital (later Oslo University Hospital), the Norwegian 
School of Sports Sciences and the Norwegian Sports Medicine Clinic (NIMI). Patient 
inclusion was conducted by Lars Nordsletten and Linda Fernandes at Ullevål University 
Hospital between April 2005 and October 2007. Linda Fernandes defended her PhD 
thesis, comprising four Papers which all emerged from this project, in January 2011. 
 
This PhD thesis is a 2.4-6.1 year follow-up of the RCT and consists of three Papers. In 
Paper I and II the long-term results of exercise therapy and patients education in patients 
with hip OA is evaluated, whereas the validity and reliability of a questionnaire assessing 
physical activity is investigated in Paper III. A total of 109 patients were included in the 
RCT. Initially, all 109 patients participated in an education program, before the patients 
were randomised to either an exercise group, participating in a 12-week exercise therapy 
program especially developed for patients with hip OA, or to a control group, receiving no 
further treatment. Follow-ups were conducted at four, ten, 16 and 29 months, and at 3.6-
6.1 years after inclusion. Assessments included outcome measures of impairments and 
activity limitations, patient-reported outcome measures, and time to THR surgery. Forty 
patients from the RCT were included in the reliability and validity study. Further long-
term follow-up of the RCT with assessments at five and ten years after inclusion are on-
going. 
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INTRODUCTION 
 
Osteoarthritis and its pathogenesis 
Osteoarthritis is a degenerative joint disease which affects the synovial joints resulting in 
pathological changes in the articular cartilage and its surrounding tissue49, 62. In healthy 
joints the primary function of the cartilage is to distribute joint loading and decrease 
friction between the joint surfaces. In early OA the biomechanical properties of the 
cartilage is comprised, and further disease development includes cartilage loss which 
eventually extends the cartilage and exposes the subchondral bone62. Remodelling and 
sclerosis of subchondral bone occurs, with formation of bone cysts and osteophytes at the 
joint margins27, 62. Thickening of the joint capsule, and hypertrophy and fibrosis of the 
synovium is common62. In early disease intermittent episodes of pain are common, as a 
dynamic process with alternating cartilage damage and attempts of repair take place. 
Later, in more severe disease irreversible and progressive pathologic changes may 
occur111. Traditionally OA have been regarded as a mechanical rather than inflammatory 
disease. Later, however, it has been found that inflammatory factors may contribute to 
disease development20, 46, possibly influenced by a systemic metabolic component198. 
Hence, the development of OA seems to be complex and different phenotypes of the 
disease may exist.  
 
Clinical symptoms, structural changes and the diagnosis of hip OA 
The main clinical symptoms in hip OA typically comprise pain, functional limitations, and 
joint stiffness49, 62, 111. Clinical examination reveals tenderness, restricted ROM, alterations 
in gait pattern, and muscular weakness and atrophy111. These features, accompanied by 
higher age, make it rather easy to suspect OA. The clinical criteria of the American College 
of Rheumatology (ACR)5 include the presence of pain in combination with 1) hip internal 
rotation ≥15 degrees, pain during internal rotation, morning stiffness for ≤60 minutes, 
and age >50 years, or 2) hip internal rotation <15 degrees, and an erythrocyte 
sedimentation rate (ESR) ≤45 mm/hour or hip flexion ≤115 degrees if no ESR was 
obtained. 
 
Radiographic examination is usually conducted to confirm the clinical diagnosis. 
Radiographic definition of hip OA is based on the presence of joint space narrowing, with 
or without accompanying osteophyte formation, subchondral bone cysts and sclerosis114. 
Several systems of assessing radiographs of the hip exist8, 9, 36, 40, 128, with the minimum 
joint space (MJS) width method showing measurement properties that are both superior 
to other radiographic criteria for disease and also with a stronger association with self-
reported pain32, 36.  According to Chu Miow et al.32 there is evidence for a weak 
association between the MJS and the patients’ symptoms and for a predictive validity for 
subsequent THRs. 
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The severity of clinical symptoms in hip OA is poorly correlated with the structural 
changes21, 32, 36, 142, 175. Radiographic findings of structural joint damage consistent with 
OA are common in the elderly population with or without the presence of pain38, and 
patients with advanced structural changes within the joint may have few or no clinical 
symptoms. On the contrary, patients presenting with pain and other symptoms of OA, 
may have little or no radiographic evidence of OA, as plain radiographs can only capture 
the structural changes in the joint which occurs relatively late in the disease process. This 
is clearly shown in the study by Birrell et al.21 where 41 %, 56 %, and 3 % of patients 
presenting with no hip pain had none, mild or severe evidence of radiographic hip OA, 
respectively. Among patients presenting with hip pain, 29 %, 55 %, and 16 % had none, 
mild or severe radiographic hip OA, respectively21. As the articular cartilage is both 
aneural and avascular it is incapable of directly generating pain111. Loss of cartilage, 
resulting in the joint space narrowing visible on radiographs, is therefore not necessarily 
accompanied by pain. This can partly explain the poor correlation between clinical 
symptoms and structural changes. However, the subchondral bone, periosteum, 
periarticular ligaments and muscles, synovioum and joint capsule are richly innervated 
by nociceptive fibres111. Furthermore, joint pain in OA is typically exacerbated by activity 
and relieved by rest, while pain at rest and during the night may be present in more 
advanced disease111, 112. According to Dieppe and Lohmander49, pain in OA should be 
assessed within a biopsychosocial framework including interaction between activity, 
incidents within the joint, pain sensitisation and the patient’s perception of pain.  
 
The prevalence and burden of OA 
In a systematic review by Dagenais et al.38 the estimated reported prevalence of 
radiographic hip OA varied from 0.9 % to 27.0 %, giving an overall mean prevalence of 
8.0 % in the general adult population. Higher prevalence was associated with higher age 
(from 55 to 80 years), and studies using the Kellgren and Lawrence scoring system 
reported higher prevalence of hip OA38. Pereira et al.177 conducted a systematic review to 
evaluate the differences in prevalence of OA according to case definition. Whereas the 
overall prevalence of hip OA was 10.9 %, radiographic OA presented a higher prevalence, 
and self-reported and symptomatic OA were less common. Twenty-seven studies on the 
prevalence of hip OA was included in the review, 19 of them reported prevalence of 
radiographic hip OA ranging from 1-45 %, four studies reported prevalence of self-
reported hip OA from 5.5-9-7 %, and four studies reported prevalence of clinical and 
radiographic hip OA from 0.9-7.4 %177. In a population-based study conducted in North 
Carolina, US, 28 % of persons older than 45 years had radiographic findings consistent 
with hip OA, but only 10 % presented both clinical and radiographic evidence of the 
disease121. Other population-based studies have reported somewhat lower prevalence of 
clinical and radiographic hip OA, 2.8 % in Turkey242 and 2.5 % in France91. In Norway, the 
prevalence of self-reported hip OA have been found to be 5.5 % in the general adult 
population90. These prevalence estimates confirm that only a proportion of individuals 
with pathological radiographic findings present clinical symptoms of OA. The prevalence 
of hip OA has remained relatively stable over many decades39, but OA is considered to 
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represent a growing epidemic, due to both longer life expectancy, and the increasing 
incidence of obesity and inactivity166, 238. 
 
Musculoskeletal disorders are among the major contributors to the global burden of 
disease, particularly in high-income, western countries and in the elderly population228. 
Kingsbury et al.130 studied the impact of OA in five large European countries and 
concluded that the impact of OA on health status and work productivity was substantial. 
Furthermore, expenses related to direct and indirect medical costs, and work disability in 
OA are extensive81, 82, 179, 193. In a Norwegian report, musculoskeletal disorders are 
referred to as the largest expenditure in the somatic specialist health services, with 
primary joint replacements being highlighted as especially costly214. To limit the impact 
of the disease on decreased health status and work ability and avoid a further increased 
THR rate, and thereby reduce healthcare costs, a shift towards more preventive 
interventions and early stage treatment is needed. 
 
Natural history and progression of hip OA 
Although OA is commonly regarded as a steadily progressive disease, its natural course is 
poorly studied. Disease progression may involve worsening of pain and symptoms as well 
as structural progression which may result in end-stage disease requiring surgical 
treatment. However, this seems to vary widely between persons and in some cases 
progression to severe disease never occurs49, 111. According to Dennison and Cooper in 
Brandt et al.45, 19-83 % and 29-65 % of patients with hip OA experienced clinical 
worsening and radiographic progression, respectively, within 2.3-12 years. Van Dijk et 
al.224 conducted a systematic review of the literature to evaluate the course of functioning 
in hip OA. They found that pain and functional status seemed to deteriorate slowly at the 
beginning, but after three years a worsening was evident224. Furthermore, the findings in 
a recent study by Eitzen et al.57 (submitted manuscript) suggest that a subgroup of 
patients, initially presenting with mild to moderate hip OA, did not progress clinically or 
radiographically over 6.6 years. Based on the general consensus that total joint 
replacement surgery is appropriate only in advanced stages of the disease, joint 
replacement may be interpreted as a result of disease progression1, 7, 52, 157. While the 
lifetime risk of clinical and radiographic hip OA have been estimated to be 25.3 %165, the 
lifetime risk of THR have been estimated to be 10.1-11.6 % in women and 7.1-9-9 % in 
men24, 37. 
 
A limited number of studies have investigated the long term course in subjects with 
radiographic evidence of hip OA, not necessarily accompanied by clinical symptoms. 
Franklin et al.74 found that 17 % of patients presenting with only radiographic signs of 
hip OA had gone through THR surgery within 11 to 29 years. Additionally, Lane et al.139 
found that within 8.3 years, 13 % of women with radiographic hip OA had gone through 
THR, 23 % had increased lower limb disability, and 65 % had progressed 
radiographically or had gone through surgery. Disease progression was found to be 
greater in patients who presented clinical symptoms of hip OA in addition to radiographic 
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evidence, with 24 % going through THR within 8.3 years139. Ledingham et al.143 and 
Dieppe et al.47 studied disease progression in patients presenting with both clinical and 
radiographic evidence of OA. Ledingham et al143 found that after 3-72 months, 66 % of 
the patients had increased pain, 10 % had experienced a functional decline, and 15 % had 
radiographic worsening, defined as a change in in Kellgren and Lawrence grade. However, 
57 % were classified as having a Kellgren and Lawrence grade 4 at inclusion, and could 
thus not progress further. In total, 53 % of the hips had been replaced within 3-72 
months143. Dieppe et al.47 found that 39 % of the patients had improved and 43 % had 
worsened after three years, and 21 % had improved and 54 % had worsened after 8 
years. Thirty-two percent and 48 % had undergone THR prior to the three and eight year 
follow-up, respectively47. In patients presenting with hip pain, but no radiographic 
evidence of hip OA, 15 % and 28 % had worsened after three and six years, respectively, 
and 12 % and 22 % had gone through THR within three and six years, respectively149. In 
the study by Fernandes et al.65, which reported the short-term results of the RCT on 
which this thesis is based, 15 % of patients presenting with clinical and radiographic hip 
OA had gone through THR within 16 months, indicating that some patients experienced 
substantial progression in a relative short period of time.  
 
Summed up, the findings in these studies suggest that the natural course of hip OA is 
multifaceted. Some patients experience diminutive clinical changes over extended 
periods, some remain unchanged or even temporarily improve, while others show a rapid 
decline with disabling impacts within few years27. Furthermore, rapidly developing 
radiographic changes have been found to have a negative effect on self-reported pain and 
function235. 
 
The reasons for this large variability in the natural course of the disease are not fully 
understood. However, higher age, female sex, narrower joint space, bony sclerosis, 
femoral osteophytes and increased hip pain have all been found to be associated with a 
more rapid disease progression143, 240. Additionally, older age125, 240, higher body mass 
index (BMI)12, 67, 68, 125, 188, 231, narrower joint space and femoral osteophytes240, activity-
demanding work68, intensive exercise161, higher education and willingness to consider 
surgery101 have been identified as potential risk factors for THR, suggesting that some of 
these factors might accelerate disease progression. Furthermore, it has been suggested 
that idiopathic hip OA characterised by superior or medial migration of the femoral head 
follow different natural courses, with OA with medial migration having better long-term 
prognosis98. The increased risk of radiographic hip OA in siblings of patients with 
manifest severe hip OA indicate that hip OA is also under strong genetic influence140. 
Finally, the overexpression of inflammatory mediators in synovial tissue in early 
compared to late knee OA may be associated with the progressive cartilage degradation 
seen in some patients19.  
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Treatment recommendations in hip OA 
It is recommended that general information on the disease, advice on life-style 
alterations, exercise and physical activity should be provided to all patients with hip OA 
as a first-line treatment to empower self-management of the disease34, 63, 106, 244. Patient 
education and exercise therapy can, therefore, be considered as part of the core 
treatment in lower extremity OA. The use of pharmacological interventions should be 
considered in patients with consistent symptoms and clinical findings. Furthermore, 
invasive interventions are to be considered in cases with severe symptoms, where other 
treatment options have failed, with THR as the final treatment option for end-stage 
disease34, 63, 106, 244. According to the ACR 2012 Recommendations, patients with hip OA 
are also strongly recommended to participate in cardiovascular and/or resistance 
exercises, aquatic exercises, and to lose weight if overweight106, but the evidence for the 
effect of these modalities in hip OA is sparse.  Furthermore, all treatment, including 
information and education, lifestyle changes, and exercise therapy, should be 
individualised for each patient63. 
 
As there is consensus regarding physical activity and exercise recommendations across 
the many clinical guidelines, future effort should target implementation of these 
guidelines in primary and secondary health care practices141, 169. Only 42 % of patients 
with self-reported doctor-diagnosed OA reported that they had received advice on 
increasing their level of physical activity, even if it is considered as part of the core 
treatment in OA69.  
 
Patient education 
For educational modalities, strong evidence has been established for a negligible to small, 
but statistically significant effect, with effect sizes of 0.06-0.12 for pain and 0.06-0.07 for 
physical function232, 244. According to the Osteoarthritis Research Society International 
(OARSI) recommendations for the management of hip and knee OA244 and the European 
League Against Rheumatism (EULAR) 2013 Recommendations for the non-
pharmacological core management63, education and information should be included in 
the core treatment in patients with lower limb OA, as it is believed to be essential to 
achieve adequate self-management of the disease. However, in a recent review it was 
concluded that self-management programmes have minimal effect in patients with OA135. 
 
Exercise therapy 
Exercise therapy has been found to be beneficial in reducing pain and improving physical 
function in manifest lower limb OA75, 76, 103, 223, 244. As few RCTs have included patients 
with hip OA only, evidence for the effect of exercise is mainly based on the many trials 
that have included patients with knee OA. Thus, the aggregated effect estimates of 
exercise in knee and hip OA reported in meta-analyses may be less valid for patients with 
hip OA only. Knowledge on the long-term effects of exercise therapy in OA is sparse, as 
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most studies only evaluate short-term effects42. Consequently, exercise has currently no 
evidential long-term effects on pain and/or physical function in patients with knee 
and/or hip OA183. However, it has been suggested that implementation of additional 
booster sessions may improve the long-term effect183. Furthermore, adherence to the 
recommended exercises has been found to be associated with better treatment outcomes 
in the long-term182. 
 
In hip OA, effect sizes of 0.33-0.38 for pain have been reported for exercise 
interventions76, 103, 244. These effect estimates are similar to or larger than the 
demonstrated effect of commonly used analgetisc, but without the potential side effects of 
pharmacological treatment.  Fransen et al.76 estimated an effect size of 0.10 for physical 
function after exercise therapy, but this estimate was based on only one RCT. Effect has 
been found to be larger for exercise interventions administered in person103. The limited 
number of RCTs conducted in the field of hip OA and their relatively small sample sizes 
diminishes the possibility to calculate effect estimates and restricts the confidence of the 
estimates. 
 
The study by Tak et al.209 was the only RCT to evaluate the effect of exercise therapy in 
patients with hip OA only published prior to the start of our RCT. They studied the effect 
of an exercise program designed for patients with hip OA, which comprised strengthening 
exercises, health education and ergonomic advice44. The exercise program, provided as 
group sessions over eight weeks, had a positive effect on both pain and self-reported 
physical function in patients with clinical diagnosis of hip OA (mean age of the included 
patients 68 years, 68 % women)209. In 2010 the results of the 16 month follow-up of our 
RCT was published (mean age of the included patients 58 years, 56 % women)65. No 
significant difference in self-reported pain was revealed between the group receiving 
both patient education and supervised exercises compared to the group receiving patient 
education only. However, a significant difference was found for self-reported physical 
function in favour of the exercise group65. The same year, Juhakoski et al.124 showed that 
patients with clinical and radiographic hip OA (mean age of the included patients 67 
years, 70 % women) who were given one weekly exercise session for 12 weeks and four 
additional booster sessions, had better effect in self-reported physical function after six 
and 18 months, compared to patients receiving usual care. In addition, French et al.78 
found that eight exercise sessions provided over an eight week period, with or without 
additional manual therapy, provided beneficial results in self-reported physical function 
nine months later, compared to waitlist controls. The patients included in the study had 
clinical and radiographic hip OA (mean age of the included patients 62 years, 64 % 
women)79. Summed up, these recent publications suggest that exercise therapy improve 
physical function in patients with hip OA over 6-18 months follow-up, but the results are 
less consistent for pain. 
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Pharmacological treatment  
Optimal management of hip OA requires a combination of non-pharmacological and 
pharmacological treatment modalities243. The ACR 2012 Recommendations106 and the 
EULAR evidence based recommendations243 both recommend paracetamol to be the 
analgesic of first choice in patients with mild to moderate pain, while non-steroidal anti-
inflammatory drugs (NSAIDs) should be added in patients who respond inadequately to 
paracetamol. The use of opioids is generally not encouraged, but Hochberg et al.106 
suggests that patients with inadequate response to other pharmacological treatment, 
who are unwilling to or cannot undergo THR, may use opioids. The effect sizes have been 
calculated to be 0.14 for paracetamol, 0.29 for NSAIDs, and 0.24-0.58 for other 
pharmacological treatments, including diacerin, cox-2 inhibitors, chondroitin sulfate and 
glucosamine sulphate243. Further investigation on whether long term use of symptomatic 
slow acting drugs in OA, including glucosamine sulphate, chondroitin sulphate and 
diacerin, can comprise a structure-modifying effect on joint cartilage, synovium and 
subchondral bone, and thus postpone joint replacement, is encouraged106, 243.  
 
Surgical treatment with THR 
There is general consensus that THR is an appropriate treatment option in cases of 
advanced OA, where non-surgical treatment has failed. The effect of THR has not been 
evaluated by comparing it to a control group following a randomised study design. 
However, effect sizes of 1.7-2.6 for pain, 1.0-2.2 for stiffness, and 1.8-2.9 for physical 
function have been reported for post-operative outcome after THR in non-controlled 
follow-up studies159. According to Fitzpatrick et al.66 54-86 % of the patients were rated 
as having good to excellent postoperative results four to eleven years after surgery. Thus, 
THR has been considered a successful surgical treatment modality, of which the majority 
of patients can expect improved function and reduced pain for several years, and older 
patients may never need a revision of the prosthesis66. Cost benefit calculations have 
revealed a larger expected cost in younger patients, as they most likely will require future 
THR revisions66 Nevertheless, the quality adjusted life-years has been shown to be higher 
in younger patients66, 190. Overall, THR thus seem to be effective in terms of improving 
health-related quality-of-life dimensions60. Men seem to benefit more than women, as do 
persons with poorer preoperative outcomes, while comorbidities have been found be 
associated with an inferior postoperative result60, 100. However, Räsänen et al.190 found 
that only 58 % of the patients had experienced an improvement larger than the minimal 
clinically important difference (MCID) after one year. Furthermore, according to a review 
by Vissers et al.227 full recovery of physical function after THR is not obtained. Perceived 
physical function improved from 50 % preoperatively to 80 % 6-8 months 
postoperatively of that of healthy controls. Furthermore, functional capacity improved 
from 70 % to 80 %, and actual daily activity increased from 80 % to 84 % of that of 
healthy controls227. Nilsdotter et al.172 found that patients who underwent THR had 
poorer physical function 3.6 years after surgery compared to a reference group, but 
health related quality of life was similar in the two groups. Additionally, Harding et al.96 
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and De Groot et al.43 found that despite improvement in pain, patient-reported function, 
physical performance and patient-reported physical activity after joint replacement 
surgery of the knee or hip, none or a very small increase was found for objectively 
measured physical activity level. 
 
For the 5-year period 1996-2000, the average annual incidence rate for THR due to 
primary hip OA in Norway was 85 per 100.000, with an increasing incidence rate over the 
years152. A higher THR incidence was associated with older age and female sex2. In a large 
prospective population-based study in Norway, Flugsrud et al.68 found that 1.3 % had 
gone through THR due to primary hip OA within nine years. This was in line with the 
findings by Frankel et al.73 who estimated the prevalence of hip disease severe enough to 
require THR surgery to be 1.5 % in the general population. In 2012, 7786 THRs were 
conducted in Norwegian hospitals, representing a 17 % increase since 2007, and a 26 % 
increase since 2002. Over the same period the number of THR revisions have increased 
even more, with a 25 % increase since 2007, and a 36 % increase since 2002167, 168.  
 
According to Gossec et al.87, clinical disease severity varies widely at the time of THR in 
different orthopaedic centres across Europe. Clearly defined indications for THR surgery 
would be helpful in selecting those patients who are likely to benefit most from surgical 
treatment. Several attempts have been made to identify criteria for surgery54, 87, 158, 186 but 
still no general agreement regarding explicit criteria for THR exist. Based on the 
increasing number of THRs and the accompanying health care costs, and the increased 
attention towards the importance of early initiation of secondary preventive actions, a 
need for a shift towards non-surgical treatment approaches has been proposed28, 84, 110. 
According to Hunter110, the focus in OA research has been on pain relieving end-stage 
treatment in persons with established OA, rather than treatments to prevent onset and 
progression of the disease.   
 
Outcome measures in OA 
Measuring treatment effect and Disease Progression 
The efficacy of treatment interventions in hip OA can be evaluated by patient-reported 
assessments of pain, function, and stiffness as well as by patient-reported or clinician-
rated evaluations of treatment response and disease status. Instruments used to measure 
outcome should be valid, reliable and responsive to change. Furthermore, the use of 
already published outcome measures has been encouraged, to allow comparison across 
trials and treatments6. To facilitate standardisation among the diverse measures that are 
available, the OARSI and the Outcome Measures in Rheumatology (OMERACT) have 
recommended a core set of outcome domains to be used in clinical trials6, 18. According to 
these recommendations, assessment of pain, physical function and patients’ global rating 
should be included as a core set of outcome measures. In addition, radiographic 
assessment is suggested to be conducted in studies lasting longer than one year. Several 
other outcome measures, including measures of stiffness, functional performance and 
time to surgery, have been suggested to be included as optional, additional measures6, 18. 
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Patient-reported outcome measures, including VAS, numeric rating scales, and disease-
specific outcome measures, such as the Lequesne Index146, the WOMAC17, and the Hip 
disability and Osteoarthritis Outcome Score171 have been widely used. Disease-specific 
questionnaires are easy to administer, their perspective is highly patient-focused, and 
many of them have been found to have acceptable validity and reliability in OA 
populations. Furthermore, performance based outcome measures can provide important 
supplementary information concerning physical function. The inclusion of both patient-
reported outcome measures and outcome measures assessing activity limitations are 
therefore encouraged as they are likely to measure different constructs of function241. 
Recently, a consensus-derived set of performance based tests to assess physical function 
in patients with hip or knee OA have been proposed as suitable for use in clinical trials in 
lower limb OA50. Additionally, evaluation of treatment effect on specific impairments, 
including ROM and muscle strength, may be valuable, as they are suggested to be 
associated with functional performance and self-perceived physical function13, 14, 156, 195, 
206. Additionally, decreased hip ROM and lower limb muscle strength has been 
demonstrated in patients with hip OA when compared to healthy controls14, 195, with 
larger deficits in patients with more severe disease122.  
 
Based on the general consensus that total joint replacement surgery is appropriate in 
advanced OA, it may be interpreted as an end-point representing disease progression. 
Time to total joint replacement has been evaluated in trials evaluating the efficacy of 
medications with potential structure-modifying effect, including symptomatic slow acting 
drugs in osteoarthritis26, 53, 162, but may also be applied in studies evaluating long-term 
results after non-surgical, non-pharmacological treatment modalities181.  
 
Measuring physical activity 
Physical inactivity has been referred to as the greatest public health problem of our time 
219. Engagement in moderate to vigorous physical activity for at least 30 minutes per day 
is thus recommended99, 174, 239. Patients with knee and hip OA are found to be less 
physically active than the general population, with only 14-30 % fulfilling these 
recommendations61, 105, 203. However, the importance of exercise and physical activity in 
OA should be particularly emphasized because of its beneficial impact on symptoms and 
function55. Advice on physical activity and exercise are already incorporated in most 
clinical guidelines for management of lower limb OA169. However, the dose-response 
relationship of exercise therapy interventions is hard to establish, partly due to the 
difficulties in measuring the amount and intensity of exercise and physical activity. For 
the same reason it is challenging to evaluate if interventions aiming to increase physical 
activity actually induce changes. Thus, valid and reliable methods for measuring physical 
activity represent a key component in studying its health effects. Furthermore, 
dimensions of physical activity including frequency, duration and intensity are important 
when the effect of physical activity is evaluated211. 
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Several methods for assessing physical activity are currently available. They can be 
categorised into three main groups; Self-reported methods (questionnaires, diaries); 
activity monitors (pedometers, accelerometers, heart rate monitors); and direct 
measures of energy expenditure (oxygen consumption, doubly labelled water method). 
Self-reported outcome measures are frequently used, as they are inexpensive and easy to 
administer in large clinical trials and epidemiological studies. They have the potential to 
capture intensity, duration, and frequency of activity, and also allow specification of type 
of exercise. However, their qualitative attributes and measurement properties are 
questioned212, with the validity and reliability being potentially hampered by recall and 
reporting bias. In contrast, accelerometers represent a method for measuring body 
acceleration, which allows for quantification of both the amount, duration and intensity of 
movement77. Unfortunately, they are rather expensive, and can only capture data for the 
particular period they are worn. Thus, accelerometers are less frequently used in larger 
clinical trials with repeated follow-ups. Direct measure of energy expenditure by using 
the doubly labelled water method is often considered to be the gold-standard for 
measuring energy expenditure/physical activity213. However, it is a time-consuming, 
costly method which requires access to both technical expertise and equipment, and is 
therefore rarely used in clinical trials.  
 
 
To summarise, hip OA is a common, potentially disabling disease which follow a 
multifaceted long-term course. A shift towards non-surgical treatment modalities has 
been advocated, and exercise is recommended as part of the core treatment in hip OA. 
Nevertheless, few RCTs evaluating the effect of exercise treatment in hip OA have been 
conducted, and knowledge on the long term effect of exercise is particularly sparse. 
Furthermore, it is unknown if exercise may serve as a secondary preventive factor, which 
can delay disease progression. The studies included in this thesis were conducted to 
enhance knowledge and explore possible causal relations in the field of effect of exercise 
in patients with hip OA.   
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AIMS OF THE THESIS 
 
 
General aim 
The overall aim of this thesis was to evaluate the long-term effects of exercise therapy in 
addition to patient education (exercise therapy group) compared to patient education 
only (control group) in patients with hip OA. 
 
Specific aims 
I To evaluate the long-term results (29 months) in the exercise therapy group 
compared to the control group by selected outcome measures of impairments and 
activity limitations, including hip ROM, muscle strength, walking capacity and pain 
during walking. (Paper I)  
 
II To evaluate the cumulative 6-year survival of the native hip to THR in the exercise 
therapy group compared to the control group. (Paper II) 
 
III To evaluate the long-term results (29 months) in the exercise therapy group 
compared to the control group in self-reported pain, stiffness and physical 
function. (Paper II) 
 
IV To evaluate the test-retest reliability and the construct validity of the PASE, a 
questionnaire assessing level and intensity of physical activity, in patients with hip 
OA. (Paper III) 
 
 
The following null hypotheses were generated: 
 
I There is no difference between the exercise therapy group and the control group 
over the 29 month follow-up period in hip ROM, muscle strength, walking capacity 
and pain during walking. (Paper I) 
 
II There is no difference between the exercise therapy group and the control group 
in the 6-year cumulative survival of the native hip to THR. (Paper II) 
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MATERIAL AND METHODS 
 
Ethical considerations 
All patients included in this thesis signed a written informed consent prior to inclusion. 
The informed consent included information about the background and the overall aim of 
the study interventions, in addition to the randomisation process, the follow-ups and 
outcome measures included. The patients were also informed that no health risks were 
associated with participation in the study, but that the exercise sessions might induce a 
temporary increase in pain. They were informed that they could withdraw their consent 
at any time without giving any reason. Based on the fact that all patients diagnosed with 
hip OA are recommended to be provided information about the disease, we considered 
the inclusion of a true control group receiving no treatment to be unethical. Thus, all 
patients included in the RCT participated in a structured patient education program. 
Therefore, instead of comparing exercise therapy to a control group receiving ‘no 
treatment’, we compared exercise therapy and patient education to patient education 
only. 
 
Patients participating in the reliability and validity study (Paper III) signed an additional 
written informed consent including information about the purpose of the study, the study 
procedure and the assessments.  
 
The study was approved by the Regional medical research Ethics Committee, and the 
patients’ rights were protected as the study was carried out in compliance with the 
Helsinki Declaration.  
 
Study design 
The study was designed as a randomised, parallel group, single-blinded, controlled trial 
with repeated follow-up assessments (Figure 1). Paper I and Paper II were both based on 
the RCT design. 
 
Additionally, a study was conducted to evaluate test-retest reliability and construct 
validity of the PASE (Paper III). 
 
Subjects 
The inclusion and exclusion criteria for the RCT was selected to ensure that the patients 
enrolled in the study had clinical and radiographic hip OA, without concomitant back or 
knee pain. Inclusion criteria comprised age between 40 and 80 years, hip pain for at least 
three months, radiographically verified hip OA, and an Harris Hip Score (HHS) between 
60 and 95 points. Radiographic evidence of OA was based on assessment of the MJS 
according to Danielsson’s criteria40, i.e. MJS <3 mm in patients aged 70 years and older, 
MJS <4 mm in patients younger than 70 years, or >1 mm difference in MJS between the 
hip joints. Clinical symptoms of hip OA was defined as presence of hip pain for three 
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months or longer and an HHS ≤95 points. The HHS is a clinician administered, disease-
specific tool to evaluate hip pain, hip function and hip ROM, which is rated worst to best 
on a 0-100 scale97. An HHS below 60 is considered to reflect severe hip OA, and has been 
used as a criterion for THR surgery at our institution. Therefore, an HHS between 60 and 
95 points, considered to represent hip OA with mild to moderate symptoms, was used as 
an inclusion criterion in the trial. In patients with bilateral hip pain, the most painful joint 
was defined as the index joint. Patients were excluded from participation in the trial if 
they previously had undergone THR in the index joint, or if they had non-idiopathic hip 
OA, knee pain or knee OA, low back pain, or dysfunction in the lower extremities due to 
accident or disease. Furthermore, patients who had been diagnosed with rheumatoid 
arthritis, osteoporosis, cancer, or cardiovascular disease unable to tolerate exercise, were 
pregnant, or did not understand Norwegian were excluded from participation. 
One hundred and nine patients were included in the RCT (Paper I and II). A sub group of 
40 patients, recruited from the RCT, was included in the study evaluating the reliability 
and validity of the PASE (Paper III). In this study, patients who had undergone THR in the 
index joint in the period between inclusion in the RCT and September 2010 were 
excluded from participation.  
 
 
 
Figure 1. Time-line showing the milestones for the complete study from 2005 to 2012, and the 
publications originating from the study. 
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Recruitment and screening for inclusion 
The majority of the patients were recruited from the outpatient clinic at the Department 
of Orthopaedics, Oslo University Hospital. To enhance enrolment Diakonhjemmet 
Hospital, the Norwegian Sports Medicine Clinic (NIMI), and general medical practitioners 
within the Oslo region assisted in patient recruitment. Furthermore, an advertisement 
was published in a local newspaper.  
 
All screening for inclusion was conducted at the outpatient clinic at the Department of 
Orthopaedics, Oslo University Hospital from April 2005 to October 2007. Radiographic 
assessments were conducted at two radiographic clinics, or radiographs were obtained 
from the patient if he or she had gone through radiographic examination during the past 
year. All the standardised posteroanterior pelvic digitised radiographs were examined 
and the MJS was measured by one orthopaedic surgeon. Screening for eligibility in the 
study was performed by one trained physical therapist. Based on the inclusion and 
exclusion criteria the clinical assessment comprised of the HHS, questions on pain of the 
hip, knee, ankle and back, and questions on co-morbidities and additional lower limb 
dysfunction. 
 
Screening and inclusion of patients for the reliability and validity study was conducted in 
September 2010. Sixty-one patients participating in the RCT were contacted by telephone, 
and patients who were able and willing to participate, and who had not undergone THR 
in the index joint, were included in the study.  
 
Randomisation process  
The patients were randomly allocated to 1) a group receiving exercise therapy in addition 
to patient education (exercise therapy group), or 2) a group receiving patient education 
only (control group) (Figure 2). A computer generated randomisation list (block length 
10, allocation ratio 1:1) was drawn by a statistician prior to inclusion. Sequentially 
numbered, sealed envelopes were used to assign treatment for the included patients 
consecutively by a research coordinator not involved in the patient assessment or 
interventions. Allocation concealment was maintained until written informed consent 
was obtained. Assignment to treatment group was conducted after completion of the 
baseline assessments and patient education sessions. The randomisation sequence was 
also concealed from the study collaborators until treatment was assigned. 
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Figure 2. Flow-chart of enrolment, allocation, follow-up, and analysis of the patients included in 
the study. 
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Interventions 
 
Patient education 
All patients included in the RCT participated in a structured patient education program.  
The patient education program was given after the baseline assessments had been 
conducted, but prior to randomisation. The patient education program applied was 
developed particularly for patients with hip OA and has previously been described by 
Klassbo et al.132. 
 
The patient education was led by a physical therapist and given as three group sessions of 
1.5 hours over three weeks at NIMI. Oral information on OA was provided, accompanied 
by slides with text, photos and illustrations. The patients were encouraged to ask 
questions during the lessons, and topics of interest were discussed. The aim of the 
program was to reduce fear of pain, and to educate the patients about pain management, 
how to prevent or reduce impairments, and how to improve or maintain physical ability. 
Key elements at the first group meeting were information about hip anatomy, 
pathogenesis and diagnosis of hip OA, and clinical symptoms and natural course of the 
disease. At the second meeting the patients were given information about possible 
reasons for functional impairments, hereunder impaired muscle strength and restricted 
ROM, they were encouraged to be physically active, to preserve or enhance ROM, and a  
sheet describing therapeutic exercises were provided. The third meeting focused on pain 
and techniques for self-management of pain, and information on additional treatment 
options, including physical therapy, pharmacological treatment and surgical options, 
were given. 
 
Patients who were randomised to the control group attended a visit to a physical 
therapist two months after finishing the patient education program at NIMI. A two month 
visit at a physical therapist was originally described as part of the patient education 
program132, but was not provided to the patients randomised to the exercise therapy 
group because they already attended weekly sessions with a physical therapist through 
the exercise therapy program. 
 
Exercise therapy 
The applied exercise therapy program was developed within our research group and has 
previously been published by Fernandes et al.64. It was especially designed to target 
impairments and functional disability in patients with hip OA, aiming to reduce pain, and 
improve muscle strength, flexibility and overall physical function. Thus, an exercise pool 
consisting of 26 exercises on warm-up, resistance exercises, functional exercises and 
stretching/flexibility exercises was composed.  
 
Warm-up was conducted by 5-10 minutes of cycling on a stationary bike or walking on a 
treadmill at an intensity of 12-13 on the Borg Rating of Perceived Exertion Scale25. Ten 
strength training exercises for hip and core muscles, including leg extension, leg curl, hip 
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extension, hip abduction, heel-raise, crunches, and bridging were included in the program. 
Dosage, progression and frequency of the strengthening exercises were based on the 
recommendations by the American College of Sports Medicine for exercise in healthy 
adults133. Thus, three sets of eight repetitions, aiming at 70-80% of one repetition 
maximum (1RM), were prescribed in the program, and the resistance was to be increased 
when the patient could perform more than eight repetitions. This was also in accordance 
with later described and published recommendations based on a meta-analysis 
evaluating the dose-response relationship of resistance training in older adults205. Seven 
functional exercises, including squats, single leg stance/squats, lunges, sideway lunges 
and step-up/step-down, were further included in the exercise program. The exercises 
were chosen to imitate movement during typical activities of daily living. Movement 
quality was emphasised during execution of the functional exercises. Three sets of ten 
repetitions were used, and progression was assured by increasing the level of difficulty of 
each exercise when the patients were able to perform ten repetitions or more with 
acceptable movement quality. Finally, two flexibility exercises and four stretching 
exercises were included in the exercise program. The flexibility exercises were performed 
with the patient lying on a mat with one leg suspended in a sling. Relaxed, repetitive 
movements of the leg in hip flexion and extension and in hip abduction and adduction 
were conducted for two minutes in each direction. The four static stretching exercises 
comprised extension, abduction, internal rotation and external rotation, and the patients 
were instructed to hold the static stretch for 30 seconds at the end position in each 
direction. 
 
Each exercise session consisted of a minimum of eight resistance and functional exercises, 
and lasted approximately one hour and 15 minutes. The patients in the exercise therapy 
group were to perform two to three weekly exercise sessions for 12 weeks. At least once 
weekly they were supervised by a physical therapist. The physical therapist assisted the 
patients in choosing exercises from the pool of 26 exercises, setting the initial resistance 
and regulating the progression. Furthermore, a pain scale was introduced by the physical 
therapist to assist the patient in deciding when to modify the exercise or intensity if 
unacceptable pain occurred during an exercise. The patients were informed that 
exercising could be somewhat pain provoking, but that pain should not exceed the limit 
for acceptable pain, defined as ≤3 on a VAS for pain. Compliance was based on training 
diaries filled in weekly by the patients during the 12 weeks intervention period. 
Attending at least 20 of a total of 24 sessions (≥80 %) was defined as satisfactory 
adherence. Patients in the control group did not have access to the exercise therapy 
program during the intervention period. 
 
Baseline assessments 
All baseline assessments were carried out prior to the patient education program and 
randomisation process. Patient characteristics included age, gender, height, weight, work 
status, education level, uni- or bilateral hip pain, pain duration, MJS, and HHS.  
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Outcome measures 
The outcome measures used in this thesis included measures of impairments and activity 
limitations (Paper I), time to THR (Paper II), a disease specific questionnaire (Paper II), 
physical activity questionnaires (Paper I, II, III), and accelerometer registrations of 
physical activity (Paper III) (Table 1). 
 
The primary end point in the RCT was the previously published 16-months outcome of 
the WOMAC pain subscale65. Thus, the outcome measures included in this thesis, used to 
evaluate long-term outcome of the RCT, are to be regarded as secondary outcome 
measures in the RCT. 
 
Table 1. Outcome measures in Paper I, II and III 
Paper I-III Included outcome measures 
Paper I 
Effect of exercise therapy and patient 
education on impairments and activity 
limitations in patients with hip 
osteoarthritis. A randomized controlled 
trial with 29 months follow-up 
Impairments and activity-limitations 
x Hip range of motion 
x Isokinetic muscle strength tests of knee and hip 
flexion and extension 
x Six minute walk test 
 
Activity-related pain 
x Visual analogue scale for pain during walking 
 
Physical activity level 
x Physical Activity Scale for the Elderly 
Paper II 
Exercise therapy may postpone total 
hip replacement surgery in patients 
with hip osteoarthritis: a long-term 
follow-up of a randomised trial 
Main long-term outcome 
x Survival of the native hip to total hip 
replacement 
 
Self-reported pain, stiffness and physical function 
x Western Ontario and McMasters Universities 
Osteoarthritis Index 3.1TM 
 
Physical activity level 
x Physical Activity Scale for the Elderly 
Paper III 
Reliability and validity of the Physical 
Activity Scale for the Elderly (PASE) in 
patients with hip osteoarthritis 
Physical activity level and intensity 
x Physical Activity Scale for the Elderly 
x International Physical Activity Questionnaire, 
short form 
x Actigraph GT1M accelerometer 
 
Impairments and Activity limitations (Paper I) 
The outcome measures of impairments and activity limitations included hip ROM, 
isokinetic concentric muscle strength testing of knee and hip flexion and extension, the 
6MWT, and pain during walking assessed on a VAS for pain. Assessments were conducted 
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at the follow-ups at four, ten and 29 months after inclusion. Assessment at baseline, four 
months and ten months were conducted at the Norwegian School of Sports Sciences. The 
29-month follow-up was conducted at NIMI. The outcome assessors remained blinded to 
group allocation throughout the trial. 
 
Passive hip joint ROM was measured by using a half-circle 1°-increment plastic 
goniometer with a moveable arm. Flexion, abduction and adduction were measured in 
supine position, with the opposite thigh fixated173. Internal and external rotation was 
measured in prone position, with the hip extended and the knee 90° flexed173. Hip 
extension was measured by using the modified Thomas test58, 173. Fair to good intra-rater 
reliability have been demonstrated for goniometric measurements of hip ROM in patients 
with hip OA, with ICCs of 0.50-0.94109, 131 for the different hip movements. Measurement 
error (Altman’s repeatability) has been calculated to be 21.5° for the total hip ROM, and 
between 3.9° and 10.7° for the different hip movements, smallest for extension and 
largest for internal rotation109. The standard error of measurement (SEM) have been 
calculated to be between 2.3° and 5.3° for the different hip movements, giving MDC 
ranging from 6.4° to 14.7°, smallest for extension and largest for external rotation131. 
Inter-rater reliability have been found to be poorer with ICCs below 0.73184, 215. 
 
Isokinetic muscle strength of hip and knee flexion and extension was tested by using an 
isokinetic dynamometer at baseline, four months follow-up, ten months follow-up (REV 
9000; Technogym SpA, Gambettola, Italy), and 29 months follow-up (Biodex 6000, Biodex 
Medical Systems Inc., Shirley, New York, US). Tests of knee muscle strength were 
conducted with the patient in a sitting position, with straps fixating the trunk and thigh. 
Knee joint testing range was set to 5-85° of knee flexion. Hip muscle strength was tested 
with the patient in a supine position, with fixation over the pelvis, and the opposite leg 
extended at the knee and hip. Hip joint testing range was set to 35-75° of hip flexion. The 
angular velocity was set to 60° per second (60°/s) for both knee and hip muscle strength 
testing. The test protocol included a warm-up of four repetitions, followed by a 20 second 
rest prior to the five test repetitions. For the analysis the highest peak torque value of the 
five test repetitions, measured in Newton-meter (N-m), was used. For isokinetic knee 
muscle strength testing ICCs between 0.92 and 0.94 have been reported for both flexion 
and extension30, 127, with a MDC of 22 N-m for knee extension148. In patients with hip OA 
ICCs of 0.89 and 0.75 have been reported for isokinetic hip flexion and hip extension 
muscle strength, respectively13. 
 
The 6MWT59 was conducted with the patients walking back and forth in a 20 m long 
corridor. Patients were instructed to walk as far as possible, without running, within six 
minutes. The walking distance was registered in meters and time was monitored by using 
a stopwatch. The 6MWT has been found to have acceptable reliability with an ICC of 0.94 
and a MDC of 34-61 m in patients with OA of the hip or knee117, 129, and a responsiveness 
superior to other functional tests and the WOMAC physical function subscale80, 129. The 
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MCID for the 6MWT has not been determined in patients with OA, but Pereira et al.178 
have estimated a substantial meaningful change to be 50 m in older adults. 
Immediately following the 6MWT the patients were asked to score their hip pain during 
walking on a VAS ranging from 0 to 100 mm, with 0 representing no pain and 100 
representing extreme pain. The MCID for improvement has been estimated to be -15.3 
mm in patients with hip OA221. However, as it was found to be influenced by symptom 
severity, the threshold for minimal clinical improvement was estimated to be -7.2 mm in 
patients with mild to moderate symptoms221. 
 
Total hip replacement surgery (Paper II) 
Based on the consensus that THR is appropriate only in cases of advanced disease, it may 
be interpreted as an expression of disease progression. Thus, time to THR was used as the 
main outcome measure at 3.6-6.1 year follow up, to compare the survival of the native hip 
to THR between the two groups (Paper II). All patients were instructed to consecutively 
report if and when they went through THR surgery during follow-up. Additionally, data 
on THR was recorded at the follow-ups conducted four, ten, 16 and 29 months after 
inclusion, and by contacting all patients by telephone in April and May, 2011. The mean 
time from inclusion to May 15th 2011 (end of study) was 4.8 years, ranging from 3.6 to 6.1 
years. The outcome assessor was blinded to group allocation. 
 
According to Abadie et al.1, THR is a highly relevant clinical outcome, but as no clearly 
defined criteria for when THR is to be conducted exists, it is potentially biased by non-
disease related factors. Total hip replacement is suggested to be a sensitive outcome 
measure, but its specificity and responsiveness has been questioned7.  
 
Self-reported pain, stiffness and physical function (Paper II) 
Self-reported pain, stiffness and physical function was assessed by the WOMAC. It is a 
self-administered, disease-specific questionnaire comprising three domains, pain, 
stiffness and physical function. A score for each domain is calculated separately, 
expressed best to worst on a 0-100 scale17. Calculation of the WOMAC subscale for pain is 
based on five items, with each item scored from ‘no pain’ to ‘extreme pain’ on a VAS. The 
score of each item was measured in mm by a ruler, with the average of the five items 
representing the total score for the WOMAC pain subscale. The different items addressed 
pain while 1) walking on a flat surface, 2) going up or down stairs, 3) in bed at night, 4) 
sitting or lying down, and 5) standing upright. Calculation of the WOMAC subscale for 
stiffness is based on two items addressing sensation of joint stiffness while 1) getting up 
in the morning and 2) after sitting for 30 minutes or more. Each item is scored from ‘no 
stiffness’ to ‘extreme stiffness’ on a VAS, and the average of the two items represents the 
total score for the WOMAC stiffness subscale. Calculation of the WOMAC subscale for 
physical function is based on 17 items addressing difficulties experienced while 
performing different activities, with each item scored from ‘not difficult’ to ‘extremely 
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difficult’ on a VAS. The average of the 17 items represents the total score for the WOMAC 
physical function subscale. 
 
The WOMAC has been proven to be a reliable and valid outcome measure in patients with 
lower limb OA, with adequate internal consistency demonstrated by Chronbach’s alpha 
coefficients of 0.81-0.96, acceptable test-retest reliability with ICCs between 0.43-0.93, 
Spearman’s ρ of 0.87, construct validity estimates of 0.43-0.59, and adequate 
responsiveness with effect sizes of 1.0-4.8 for THR17, 159, 201, 208. According to Angst et al.10, 
11 effects larger than 12-22 % of the baseline score can be interpreted as a clinically 
meaningful change in patients with lower limb OA. The MCID has been estimated to be 
7.5 for the pain subscale and 6.7-7.9 for the physical function subscale11, 221. The MCID 
was found to be affected by the initial degree of severity of the symptoms. Thus, the MCID 
for the WOMAC physical function subscale in patients with mild to moderate symptoms 
was estimated to be 5.3221. 
 
Physical activity assessments (Paper I, II and III) 
The PASE was used to assess overall activity level at baseline, and at the four, ten, 16 and 
29 months follow-up of the RCT (Paper I and II). Furthermore, the number of weekly 
exercise sessions was assessed at baseline and at the four months follow up. Additionally, 
the test-retest reliability and the construct validity of the PASE were investigated in 
patients with hip OA, since that had not previously been reported (Paper III). In the 
reliability and validity study we also included other outcome measures intended to assess 
physical activity level and intensity. The IPAQ was included as well as an Actigraph GT1M 
accelerometer (Acti-Graph, LLC, Pensacola, FL, USA) to examine if the PASE could validly 
assess physical activity level and intensity. 
 
The PASE is a self-administered, 7-day recall questionnaire designed to assess physical 
activity in older adults234. The Norwegian version of the PASE, which was used in this 
trial, has been slightly adapted during the translation process due to cultural 
differences153. Thus, the Norwegian version consists of 24 questions giving an overall 
PASE score ranging from 0-315, with 0 representing no physical activity and 315 
representing an extremely high activity level. The questions included in PASE address 
leisure-time, household and work-related physical activity. Participation in leisure-time 
physical activity, including light, moderate and vigorous intensity, and strengthening 
activities, is recorded as never, seldom (1-2 days per week), sometimes (3-4 days per 
week), and often (5-7 days per week). Duration is categorised as less than 1 hour, 1-2 
hours, 2-4 hours and more than 4 hours. Housework activities are recorded as yes or no, 
and paid or unpaid work, requiring some physical activity, is recorded in hours per week. 
The total PASE score was computed by multiplying time spent (hours per day) in each 
leisure and work-related activities or participation (yes/no) in household related 
activities, by empirically derived weighting, and then summarising all items. Additionally, 
the score for household-/work-related activities, the score for leisure-time physical 
activity, and the score of the items addressing light, moderate and vigorous intensity 
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were calculated separately. To evaluate its test-retest reliability, the PASE was filled in by 
the patients included in the reliability and validity study at two occasions with seven days 
in between. 
 
The IPAQ is a self-administered, 7-day recall questionnaire designed for assessing 
physical activity in adults35. The Norwegian version of the IPAQ short form was used in 
this study (http://www.ipaq.ki.se/). It consists of seven questions which include physical 
activity in all contexts of everyday life, addressing time spent on vigorous physical 
activity, moderate physical activity and walking. The IPAQ is scored by using the 
Metabolic Equivalent of Task (MET) method, where different activities and levels of 
intensity are given different MET estimates. Total MET-minutes per week, representing 
the overall activity level, was calculated. In addition, MET-minutes per week for walking 
activities, moderate activities and vigorous activities were calculated. The IPAQ was 
included in the reliability and validity study to evaluate construct validity of the PASE, 
and was thus only assessed at the first test occasion for the patients participating in this 
study. 
 
The Actigraph GT1M (ActiGraph, LLC, Pensacola, FL, USA) is an electronic motion sensor 
comprising a single plane accelerometer. Movement in the vertical plane is detected as a 
combined function of the frequency and intensity of the movement. For the analyses, a 
valid day was defined as having ten or more hours of monitor wear. Six or more valid 
days of registration were considered sufficient. The software program ActiLife (ActiGraph, 
LLC, Pensacola, FL, US) was used to initialise the Actigraphp GT1M and to download the 
recordings, and the software program SCA Analyzer (SAS Institute Inc., Cary, North 
Carolina, USA) were used to reduce data. Average counts per minute representing the 
overall activity level were calculated. In addition, the minutes spent in light, moderate 
and vigorous physical activity intensity was calculated, based on the cut-offs described by 
Troiano217 and Hansen et al.95. Furthermore, the average minutes spent in moderate to 
vigorous physical activity per day were calculated, to evaluate the proportion of patients 
who fulfilled the recommendations of at least 30 minutes of daily moderate to vigorous 
physical activity. The accelerometer recordings was used to evaluate the construct 
validity of the PASE. Therefore, the patients participating in the reliability and validity 
study to evaluate the measurement properties of the PASE, completed a seven-day 
Actigraph GT1M measurement period prior to filling in the PASE.  
 
Sample size calculations 
To evaluate sample size, a clinically relevant outcome measure must be determined prior 
to study start, together with the expected variance and the minimum difference 
considered to be clinically important for the specific outcome measure, as well as the risk 
for type 1 and type II errors (risk for a false positive or a false negative conclusion). The 
WOMAC subscale for pain was defined as the primary outcome measure for the short 
term outcome65, and risk levels for type I and type II errors were set at 0.05 and 0.10, 
respectively. Additionally, the standard deviation (SD) for the change of WOMAC pain 
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score was set to 23 mm and the mean group difference was set to 15 mm. The sample size 
calculations revealed that 49 patients were needed in each group in the 16 months 
follow-up of the RCT, published by Fernandes et al.65 (ClinicalTrials.gov number 
NCT00319423). To compensate for a possible drop-out rate of 10 %, inclusion of at least 
54 patients in each group was considered sufficient65. For the long-term outcome of the 
RCT, no new a priori statistical power analysis was performed. However, post power 
analyses were conducted for the outcome measures included in Paper I, and included in 
the Discussion section of this thesis. 
 
Developing new knowledge based on innovative ideas is considered a primary task for 
research. Hence, we decided to conduct a long-term follow-up study of the RCT based on 
the surprisingly high number of patients who had gone through THR after just 16 
months65. An additional protocol was prepared in which we specified that the patients 
were to be followed for minimum 3.5 years to assess time to THR (Paper II) 
(ClinicalTrials.gov number NCT01338532). Since these patients were included over a 2.5 
year period, the longest follow-up would exceed six years. 
 
Sample size for the reliability and validity study (Paper I) was based on previous studies 
70, 233 and on calculations suggesting that inclusion of 35 patients would provide 
correlation estimates between 0.64 and 0.89. Also, according to the model for sample size 
requirements by Donner and Eliasziw51 inclusion of 25-30 subjects seemed to be 
sufficient, based on an estimated correlation >0.85 between two measurements. Hence, 
we decided to include 40 patients in the study.  
 
Statistical analyses 
The statistical analyses included descriptive analyses (Paper I-III), mean comparison 
within and/or between groups (Paper I-III), group comparisons by mixed model analysis 
(Paper I and II), Kaplan-Meier analysis (Paper II), group comparisons by Log Rank test 
and Cox-proportional hazard model (Paper II), two-ways analysis of variance (Paper III) 
and bivariate correlation analysis (Spearman’s ρ) (Paper III). 
All analyses were performed by IBM SPSS Statistics, version 19.0 (IBM Corp., Somers, 
New York, USA), except for Paper III where the PASW Statistics, version 18 (IBM Corp., 
Somers, New York, USA) was used. Descriptive statistics were presented as mean and SD 
or frequency and percentage. P-values below 0.05 were considered statistically 
significant for all analyses.  
Paper I 
To evaluate between-group differences in ROM, muscle strength, walking capacity and 
pain during walking, a linear mixed model (variance component structure with time and 
the interaction between time and group as fixed effects and time as random effect 
intercept and slope) was used. The analyses were based on the intention to treat (ITT) 
principle. Because many patients had undergone THR during follow-up, and thus were 
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not assessed at the subsequent follow-ups, a missing value analysis was conducted to 
evaluate the pattern of missing values. The analysis revealed that missing was not 
completely at random. Thus, as a sensitivity analysis, a linear mixed model using the last 
observation carried forward technique (LOCF) was conducted to account for the poorer 
pre-operative results of those patients who had gone through THR during follow-up. To 
evaluate within-group differences from baseline to four month follow-up paired t-tests 
were applied. A linear mixed model was used to compare total PASE scores between the 
exercise therapy group and the control group. Weekly number of exercise sessions was 
reported as mean and SD. 
Paper II 
A Kaplan-Meier survival analysis was constructed to evaluate cumulative six year 
survival, and group difference was assessed with the Log Rank test. The analyses were 
based on the ITT principle. Patients were followed until time of THR in the index joint, or 
until death, drop-out or end of study. THR in the index joint was defined as event, while 
patients who were lost to follow-up, were deceased or were followed until end of study 
were treated as censored in the analysis. Time to THR was reported as median and 95 % 
confidence interval (CI). A Cox-proportional hazard model was used to calculate hazard 
ratio and 95 % CI between groups. No adjusted analysis was conducted, due to equality of 
groups at baseline. 
A linear mixed model (variance component structure with time and the interaction of 
time and group as fixed effects and time as random effect intercept and slope) was used 
to compare WOMAC scores between the exercise therapy group and the control group 
over the 29-month follow-up period. A linear mixed model was also applied to compare 
WOMAC scores prior to THR surgery or end of study between patients who went through 
THR and patients who did not. A linear mixed model was also used to compare total PASE 
scores between the exercise therapy group and the control group. Weekly number of 
exercise sessions was reported as mean and SD. 
Paper III 
Test-retest reliability of the PASE score was evaluated by calculating the ICC (two-way 
random effect model, absolute agreement). The SEM, the MDC and the limits of 
agreement (LoA) were calculated to evaluate measurement error. Additionally, a Bland 
Altman plot was conducted for visual judgment of the relationship between the individual 
mean total PASE score of the test and retest, and the difference in total PASE score 
between test and retest23. 
The construct validity of the PASE was evaluated by calculating the Spearman’s ρ 
between the total PASE score and the Actigraph GT1M total counts per minute, and 
between the total PASE score and the IPAQ total MET-minutes per week. A priori, we 
hypothesised a low to moderate positive correlation (ρ between 0.15 and 0.5) between 
the total PASE score and the Actigraph GT1M total counts per minute, and a moderate to 
strong positive correlation (ρ between 0.6 and 0.9) between the total PASE score and the 
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IPAQ total MET-minutes per week. A correlation coefficient above 0.50 between the total 
PASE score and the Actigraph GT1M counts per minute was defined as a cut-off for 
acceptable validity, as suggested by Terwee et al.213. Additionally, Spearman’s ρ were 
calculated for the PASE items for light, moderate and vigorous PA intensity and the 
respective intensity categories of the Actigraph GT1M and the IPAQ.   
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SUMMARY OF RESULTS 
 
Study I 
Two hundred and twenty patients were screened for eligibility between April 2005 and 
October 2007. One hundred and nine patients (54 % women), with a mean age of 57.9 ± 
9.9 years were included in the trial, and randomised to the exercise therapy group (n=55) 
or the control group (n=54)(Figure 2). The patients had experienced pain for 48.4 ± 51.9 
months (median 30 months), and 70 % presented bilateral hip pain. The mean MJS at 
baseline was 2.0 ± 1.1 mm, and the mean HHS was 78.4 ± 8.1. The patients randomised to 
the exercise therapy group completed a median of 20 (interquartile range 16-24) exercise 
sessions over the 12-week period, with 53 % completing ≥20 exercise sessions. One 
patient discontinued exercise after three sessions due to increasing hip pain, but no other 
adverse events were registered. 
 
At the 29 months follow-up eleven patients were lost to follow-up, three patients did not 
complete the clinical/functional tests, and 27 patients had gone through THR prior to the 
follow-up. Hence, 38 % of the patients presented missing data for the outcome measures 
of impairments and activity limitation at the 29 month follow-up. At the four month 
follow-up, immediately after completion of the exercise program, the exercise group had 
5.4 (95 % CI from 0.5 to 10.3) degrees better external rotation ROM compared to the 
control group. No other significant group differences were found at the four month 
follow-up. Within the exercise therapy group, significant improvement from baseline to 
four months follow up was found for external rotation ROM, 6MWT, and pain on VAS 
during walking, and significant decline was found for hip flexion. Within the control 
group significant improvement was found for external rotation ROM, and significant 
decline was found for hip adduction ROM and for hip flexion muscle strength. No other 
within group differences was found between baseline results and four months results. 
Over the total follow-up period of 29 months, patients in the exercise group had 
significantly less pain on VAS during walking compared to the control group (p=0.018). 
No other significant between group differences were found. The results of the sensitivity 
analysis corresponded with the findings of the main analysis. Overall, the estimated 
means for each group improved or remained relatively stable over the follow-up period.  
No group differences were found for the total PASE score over the 29 months follow-up 
period (p=0.397). The mean number of self-reported exercise sessions per week was 3.2 
and 3.7 at baseline and four months, respectively, in both groups. 
 
This study shows that exercise therapy in addition to patient education provided no 
benefit over patient education only in hip ROM, knee and hip muscle strength and 
walking capacity, but the exercise therapy group reported less pain during walking in the 
long term. 
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Study II 
Inclusion, baseline characteristics and compliance in Study II were identical with Study I. 
Data on whether THR had been performed or not was obtained from 102 patients, giving 
a response rate of 94 % at the 3.6-6.1 year follow-up. The remaining seven patients were 
treated as censored at the time of death, last follow-up, or contact during the follow-up 
period. Twenty-two patients in the exercise therapy group and 31 patients in the control 
group underwent THR within the 3.6 to 6.1 year follow-up period, giving a six year 
cumulative survival of the native hip of 41 % and 25 %, respectively (p=0.034). Cox 
proportional hazard analysis showed that participating in both exercise therapy and 
patient education had a protective effect against THR compared to patient education only 
(Hazard ratio=0.56, 95 % CI from 0.32 to 0.96, p=0.036). Median time to THR was 5.4 
years in the exercise group and 3.5 years in the control group.  
 
The exercise therapy group had better self-reported hip function prior to THR or end of 
study evaluated by the WOMAC physical function (p<0.01), but no significant difference 
were found for WOMAC pain (p=0.083) or WOMAC stiffness (p=0.112). There was no 
significant difference in PASE scores between the groups (p=0.397). The number of self-
reported exercise sessions per week was equal across the groups, 3.2 at baseline and 3.7 
at the four months follow-up. Mean MJS at baseline was 1.5 ±0.9 mm in patients who 
went through THR, compared to 2.5 ±1.0 mm in the patients who did not (p<0.01). At 
baseline, there was no significant difference between patients who went through THR 
and patients who did not, neither for WOMAC pain, stiffness or physical function. The 53 
patients who underwent THR before end of study had worse preoperative score in all 
WOMAC subscales over the 29 months follow-up period compared to the patients who 
did not go through THR or were censored at end of study (p<0.01). 
 
This study showed that participating in exercise therapy in addition to patient education 
may reduce or postpone the need for THR in patients with hip OA. 
 
Study III 
In 2010, 20 men and 20 women were recruited from the RCT for participation in a study 
evaluating the reliability and validity of the PASE.  Hence, they presented patient 
characteristics similar to the RCT but were slightly older with a mean age of 61.3 ± 10.0 
years because the study was conducted three years after the inclusion in the RCT was 
completed. 
 
The test-retest reliability was calculated based on the 33 patients who had completed the 
PASE at both test and retest. Mean days between test and retest was nine days. Mean total 
PASE score was 143 ± 71 and 125 ± 56 at test and retest, respectively. The decline in the 
total PASE score from test to retest was significant (p = 0.02). The ICC for the total PASE 
score was 0.77 (95 % CI from 0.56 to 0.88). The estimated SEM and MDC were 31 and 87 
points, respectively, and the calculated LoA ranged from -65 to 100. Furthermore, the ICC 
for household- and work activities was 0.69 (95 % CI from 0.46 to 0.84), and the ICC for 
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leisure-time activity was 0.53 (95 % CI from 0.24 to 0.74). The ICC for the different 
intensity items of the PASE was 0.46 (95 % CI from 0.15 to 0.69) for light intensity, 0.20 
(95 % CI from -0.16 to 0.51) for moderate intensity, and 0.68 (95 % CI from 0.44 to 0.83) 
for vigorous intensity.  
 
Construct validity was evaluated by calculating the Spearman’s ρ between the PASE and 
the Actigraph GT1M registrations, which was based on the 33 patients who had readable 
Actigraph GT1M files with six days or more of registration. The comparisons between the 
PASE and the IPAQ, was based on the 25 patients who had completed the IPAQ without 
missing values. The Spearman’s ρ between the total PASE score and the Actigraph GT1M 
total counts per minute and between the total PASE score and the IPAQ MET-minutes per 
week was 0.30 (p=0.089) and 0.61 (p<0.01), respectively. The Spearman’s ρ between the 
PASE items assessing different levels of physical activity intensity and the respective 
categories of the Actigraph GT1M registrations ranged from 0.20 to 0.38, being highest 
for moderate intensity. The Spearman’s ρ between the PASE items assessing different 
levels of physical activity intensity and the respective items of the IPAQ ranged from 0.29 
to 0.75, being highest for vigorous intensity. 
 
Based on the Actigraph GT1M measurements 67 % of the patients fulfilled the 
recommendations of at least 30 minutes of accumulated moderate to vigorous physical 
activity per day, and the mean time spent on moderate to vigorous physical activity was 
45 ± 32 minutes per day. 
 
These findings suggest that the PASE has moderate test-retest reliability, with acceptable 
ICC, but with large measurement error. The construct validity of the PASE was considered 
to be poor, based on a Spearman’s ρ of 0.30. Hence, the PASE was not considered to be 
able to provide valid estimates of physical activity levels and intensity. 
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DISCUSSION 
 
Main findings 
Patients with mild to moderate hip OA who participated in exercise therapy and patient 
education revealed significantly less pain during walking over the 29-months follow-up 
period compared to patients participating in patient education only. However, no 
additional effect of exercise therapy was found for hip ROM, knee or hip muscle strength 
or walking capacity. Furthermore, we demonstrated a higher six year cumulative survival 
of the native hip to THR in the exercise therapy group compared to the control group, 
suggesting that exercise therapy can postpone the need for THR in patients with hip OA. 
Exercise therapy in addition to patient education significantly improved self-reported 
physical function, but no additional effect of exercise therapy was found for self-reported 
pain or stiffness. The reliability and validity study revealed that the PASE had poor 
construct validity, with a correlation coefficient of 0.30 when compared to an 
accelerometer. Thus, the use of PASE to assess physical activity level in patients with hip 
OA cannot be recommended, despite acceptable test-retest reliability.  
 
Study design and methodological considerations 
This thesis is based on three studies originating from a RCT evaluating the effect of 
exercise therapy and patient education in patients with hip OA. In an experimental design, 
the aim is to establish a cause-and-effect relationship by manipulating an independent 
variable to evaluate its effect on a dependent variable194, 216. Randomised controlled trials 
are required to study causality inferences, i.e. the link between the cause and its effect, as 
random assignment most likely ensure equality across groups89. As the aims of Paper I 
and Paper II were to evaluate the efficacy of two different treatment modalities, the RCT 
design was a natural choice. 
  
All research designs have strengths and weaknesses influencing the validity of the 
research and the generalisability of the results. Internal validity concerns the degree to 
which all variables in a study has been successfully controlled for, to enable elimination 
of explanations other than the independent variable for the observed outcome216. The 
randomisation procedure aims at securing equal distribution of potentially confounding 
factors across the treatment groups, and can thus control for pre-study events, statistical 
regression, selection bias (for selecting treatment) and learning effect216. Furthermore, 
blinding of the outcome assessor can minimise observer bias. Inclusion of a group 
receiving ‘no treatment’ would allow comparison with the time-dependent course of the 
disease. As all patients were given the patient education program due to ethical reasons, 
the control group in our RCT, who received patient education only, cannot be considered 
to represent a ‘true’ control group, even though the expected benefits of the patient 
education are negligible135. Additionally, as no group receiving sham exercise was 
included in our RCT, we could not rule out a possible placebo effect. 
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Minimising the drop-out rate is considered to be crucial to ensure high internal validity. It 
has been suggested that a drop-out rate greater than 20 % may represent an important 
threat to the validity of the result197. At the 3.6-6.1 year follow-up (Paper II) the follow-up 
rate was excellent, as only six percent were lost to follow-up. Hence, the results of this 
analysis are less likely to be biased by drop-out. Outcome measures of impairments and 
activity limitations (Paper I) and patient-reported outcome measures (Paper II) was 
assessed at the four, ten, 16 (only patient-reported) and 29 month follow-up. 
Unfortunately, a relatively large percentage of the patients had missing observations at 
the latest follow-ups due to drop-out or THR. Consequently, overall power was reduced, 
which causes an increased risk for Type II error, i.e. to incorrectly retain the null 
hypothesis. The relatively large percentage of patients presenting with missing 
observations due to THR may have biased the results, as their presumably poorer pre-
operative results were not included in the analysis. Furthermore, the uneven distribution 
of THRs across the groups, with more patients in the control group having gone through 
THR, may have resulted in an underestimation of the effect of exercise therapy. 
 
The external validity addresses the question on generalisability, and is dependent on the 
process of patient recruitment and the eligibility criteria. The generalisability can be 
maximised by selecting participants, treatments, experimental situation, and tests that 
represent a larger population216. Selection bias may pose a threat to the external validity, 
and Altman et al7 have suggested that patients recruited to non-surgical treatment trials 
may have a stronger desire to go through with non-surgical treatment strategies. To 
evaluate the external validity potential discrepancies between the study patients and the 
population from which it is drawn must be considered216. In RCTs, inclusion and 
exclusion criteria are typically strictly formed. The inclusion rate is often relatively low, 
due to both strict exclusion criteria and unwillingness to undergo randomisation. Low 
inclusion rate can be a threat to the external validity, especially if the excluded patients 
differ from the included. In this trial the inclusion rate was 50 %. Most patients were 
excluded because they lacked radiographic evidence of hip OA, had too high or too low 
HHS, or because they had knee pain or knee OA. Thus, our findings are applicable for 
patients with clinical and radiographic evidence of hip OA, presenting with mild to 
moderate symptoms, without concomitant knee pain, knee OA or low back pain. In a 
Norwegian population-based study 36 % of patients who reported to have been 
diagnosed with hip OA, also reported to have knee OA. Thus, by excluding patients with 
knee pain/knee OA we cannot generalise our findings to the approximately 1/3 of 
patients with hip OA who have concomitant knee pain/knee OA. 
 
The interventions provided in a RCT may not have the same effect when given in another 
setting and by other providers. This also poses a threat to the external validity, which can 
be minimised by avoiding complex interventions and offer proper descriptions of the 
applied interventions. The content of both the patient education program and the 
exercise therapy program utilised in our study is easy to adopt in clinical settings, and 
detailed descriptions are readily available64, 132. According to Bagshaw and Bellomo 15, 
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actions aiming at optimising internal validity may compromise the overall 
generalisability, and advantages and disadvantages of the different actions should be 
carefully balanced. 
 
Paper III was conducted to evaluate the test-retest reliability and the construct validity of 
the PASE in this particular subpopulation of hip OA patients, since the measurement 
properties of an outcome measure is considered to be related to the population and 
context in which it is being used164. The importance of similar conditions and appropriate 
time intervals between test and retest has been emphasized213. Thus, we administered 
the PASE by mail with seven days in between, and the patients completed the 
questionnaire at home. However, the week prior to the first PASE test occasion the 
patients had worn the Actigraph GT1M accelerometer. It is suggested that accelerometry 
may modify activity patterns191, and the conditions of the seven day recall period for the 
first and second measurement occasion was therefore not fully identical. This was 
reflected by a significant decrease in PASE score from test to retest. We included both 
relative and absolute measures of reliability, as recommended by Terwee et al.213. To 
evaluate if the PASE truly measure the construct of physical activity level, we evaluated 
the construct validity by comparing it to outcome measures expected to measure the 
same construct. A correlation coefficient between the PASE and the Actigraph GT1M 
larger than 0.5 has been defined as acceptable validity213. Construct validity is often used 
to evaluate the validity of an instrument when no gold-standard is available to evaluate 
the criterion validity. However, the doubly labelled water method is considered to 
represent a gold standard for assessing energy expenditure/physical activity, and it could 
have been used as a comparison to establish the criterion validity of the PASE. However, 
we did not consider to include it in this study because it is too expensive, time-consuming 
and expertise demanding, and because it measures energy expenditure rather than level 
and intensity of physical activity.  
 
Subjects 
An age between 40 to 80 years was chosen as an inclusion criterion to reflect the age 
group with the highest incidence/prevalence of hip OA39, 90, 115, 116, 187, 245. The criteria by 
Danielsson40 was used to assess radiographic evidence of hip OA. By using these criteria, 
which are less stringent compared to other suggested cut-offs36, we aimed to include 
patients at an early stage of the disease, for which the exercise and educational 
interventions were considered to be particularly suitable. Clinical evidence of hip OA was 
based on the presence of hip pain for three months or longer and a HHS between 60 and 
95 points. Patients with a HHS above 95 and below 60 were excluded from participation 
because their hip symptoms were considered to be minimal (>95) or severe enough for 
the patients to be considered as candidates for THR surgery (≤60). 
Thus, the 109 included patients had radiographic OA, with mild to moderate clinical 
symptoms, and none of them were candidates for THR surgery at time of inclusion. They 
had no concomitant knee OA/knee pain or low-back pain, and no co-morbidities 
potentially hampering compliance to the interventions. Only three previous studies have 
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evaluated the effect of exercise interventions in patients with hip OA only79, 124, 209. Of 
these, only the study by Tak et al.209 had been published prior to the start of our RCT. 
Hence, the inclusion and exclusion criteria were carefully chosen to enable us to 
contribute to increase the level of evidence for the effect of exercise therapy in this 
specific patient group. 
 
The baseline characteristics of the patients included in this trial revealed that they were 
younger, had lower BMI, and a larger proportion of them were men, still employed and 
higher educated, compared to the patients included in other studies evaluating the effect 
of exercise treatment in hip OA78, 124, 209. Furthermore, they presented WOMAC pain, 
stiffness and physical function scores of 26.6, 34.6, and 22.3, respectively, indicating that 
they had mild to moderate pain and functional disability at the time of inclusion. 
Additionally, at baseline the patients reported a mean of as many as 3.2 exercise sessions 
per week, and their baseline activity level evaluated by the PASE was similar to healthy 
elderly153. Furthermore, the results of the Actigraph GT1M accelerometer recordings in 
the reliability and validity study of the PASE further emphasised that the patients 
included in our study were more physically active compared to what has been reported in 
other studies evaluating physical activity level in patients with OA61, 105, 203. Sixty-seven 
percent of the patients fulfilled the recommendations of 30 minutes or more of 
aggregated moderate to vigorous activity per day. Thus, a larger percentage of the 
patients in our study fulfilled the physical activity recommendations compared to the 
general adult and elderly population of Norway95. 
 
Interventions 
Both interventions offered in this trial (a patient education program132 and a supervised 
exercise therapy program64) were especially developed for patients with hip OA. As 
information is recommended to all patients with hip OA because it is assumed to be 
crucial to enhance self-management of the disease34, 63, 106, 244,  all study patients 
participated in the patient education program The patient education program focused 
also on the importance of physical activity, and provided suggestions on appropriate 
activity forms and exercises. Consequently, patients might have been encouraged to 
implement lifestyle changes, increase their physical activity level, or to adapt activity 
forms or exercises considered to be particularly valuable in hip OA. In a non-randomised 
trial, Klassbo et al.132 demonstrated that patient who were given the same education 
program which we applied in our study, remained stable over a 12-month period, while 
the control group experienced increased pain and functional limitations. However, a 
recently published Cochrane-review concluded that self-management education 
programmes provide none or small benefits in patients with OA, but that they are 
unlikely to cause any harm135. 
 
The supervised exercise therapy was provided in an individualised, semi-standardised 
manner64 to the 55 patients in the exercise therapy group as outpatient treatment by one 
of two physical therapists at NIMI. In knee OA, an approach combining exercises to 
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increase strength, flexibility, and aerobic capacity has been recommended, but no 
conclusion regarding the most efficient type of exercise have been established for hip 
OA223. However, strengthening exercises of the lower limb were particularly emphasised 
in our program, and nine resistance exercises and eight functional exercises containing a 
strengthening component were included. The patients were to perform three sets of eight 
repetitions of the resistance exercises, aiming at a resistance of 70-80 % of 1RM, with 2-3 
weekly exercise sessions were used. This was in line with the recommendations by 
Kraemer et al.134 and Steib et al.205. Training diary data revealed that only 53 % of the 
patients had completed 20 or more exercise sessions during the 12 week period. Hence, 
many patients did not exercise frequently enough to increase muscle strength. 
Furthermore, pain during training may have resulted in inadequate training intensity. 
The two flexibility exercises and four stretching exercises was included in the exercise 
therapy program aiming to improve hip ROM. Difficulties in maintaining an adequate 
stretching position and too short holding time may have resulted in inadequate stimulus 
to induce an increase in ROM. Adding a manual component to the stretching exercises 
might have increased the effect107. 
  
Despite that patient education has been considered as a part of the core treatment in OA, 
providing information on the benefits of exercise is probably insufficient to achieve long 
lasting behavioural changes135. Hurley et al.113 suggested that for patients with chronic, 
painful diseases, positive experiences with performing an exercise program is necessary 
to implement it and to believe in its effectiveness. In patients with knee pain, programs 
combining education and exercise improved the patients exercise beliefs and self-
efficacy113, 118, and patient interviews have suggested that these improvements reflect the 
patients understanding and belief in exercise as an effective self-management of the 
disease113. Thus, we cannot rule out a possible interaction effect of the two interventions 
for the patients in the exercise therapy group.  
 
Outcome measures 
The outcome measures included in this thesis comprised assessments of impairments 
and activity limitations, disease specific questionnaires, and survival of the native hip to 
THR. As the results regarding the primary outcome measure of the RCT, WOMAC pain at 
16 months follow-up, have been previously published65, the outcome measures presented 
in this thesis are to be considered as secondary, exploratory, pre-defined outcome 
measures. 
 
In Paper I we reported the treatment effect on specific impairments and activity 
limitations, including hip ROM, isokinetic knee and hip muscle strength, 6MWT and pain 
on VAS during walking. These measures were chosen because they address body 
impairments and activity limitations found in patients with hip OA14, 195, and had been 
targeted in the exercise therapy program64. After our study was initiated, the OARSI 
recently recommended a set of five performance-based tests to be used as a complement 
to patient-reported measures in patients with hip OA50. This set of tests comprised the 30 
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seconds chair-stand test, 40 meter fast-paced walk test, a stair-climb test, timed up-and-
go test and the 6MWT. Of the performance-based tests recommended by OARSI50, only 
the 6MWT was included in our RCT. Furthermore, we assessed pain during walking on a 
VAS immediately after the 6MWT because it was considered to represent activity-related 
pain. Pain in OA, particularly at an early stage of the disease, is typically described as 
being aggravated by activity and relieved by rest. Thus, we considered it to be of 
particular interest to assess activity-related pain in this patient group, presenting with 
mild to moderate pain and symptoms at inclusion. In contrast, in the WOMAC pain 
subscale three of five items is regarding pain at rest17, and it might thus be less 
responsive for improvement in this particular patient group. 
 
Time to THR was defined as the main outcome measure for the 3.6-6.1 year follow-up 
(Paper II). Previous studies have also assessed time to THR to evaluate the effect of 
exercise and potentially disease-modifiable pharmacological interventions in lower limb 
OA26, 53, 162, 180. However, the use of THR as an outcome measure is hampered by the lack 
of generally accepted criteria for THR. Higher levels of pain and functional disability have 
been found to be associated with a higher THR rate151, but as clinical severity varies 
widely at the time of THR self-reported pain and function cannot identify patients who 
are in need of surgery48, 88. According to Abadie et al.1 and Altman et al.7, THR is a highly 
relevant clinical outcome, but it is potentially biased by comorbidities and 
contraindications for surgery, as well as the patient’s preferred choice of treatment. Still, 
we consider the use of THR to evaluate long-term treatment effect in this trial to be 
appropriate, due to the randomisation procedure which presumably secure an even 
distribution of potentially confounding factors across the groups. Unfortunately, we did 
not specify criteria for when THR was indicated prior to the start of the study. Also, we 
did not assess MJS, HHS, pain level and indication for THR immediately prior to surgery. 
However, we assume that the majority of the patients who underwent THR during follow-
up had an HHS below 60 points at the time of surgery. This assumption was based on 65 % 
of the patients being operated at Oslo University Hospital, where an HHS below 60 points 
has been interpreted as an indication for THR. This HHS cut-off has also been used at 
other hospitals. Furthermore, pain experience, including pain intensity, impact on quality 
of life and ability to cope with pain, has been identified as the main reason for patients 
considering themselves as candidates for joint replacement surgery72. 
 
The disease-specific WOMAC questionnaire was included in Paper II with the purpose of 
comparing self-reported levels of pain, stiffness and physical function prior to THR or end 
of study between the exercise therapy group and the control group. The WOMAC has 
been extensively used and it has been suggested to be a reliable and valid instrument for 
measuring self-perceived pain and function in patients with hip OA17, 208. McConnell et 
al.159 stated that the validity, reliability and responsiveness of the pain and physical 
function subscales are satisfactory, but the measurement properties of the stiffness 
subscale have not been well demonstrated. Additionally, the WOMAC may lack 
discriminant validity185, and its responsiveness have been questioned in patients with 
49 
 
less severe symptoms due to floor effects171. Pain and physical function are related 
concepts, and since the WOMAC pain is filled in immediately prior to the WOMAC 
physical function and the two subscales have a parallel item content, it is not unlikely that 
reflections of pain can influence the WOMAC physical function score185.  
 
In 2005, when our RCT started, few studies had evaluated the measurement properties of 
the PASE. The findings in the studies by Washburn233, 234, Schuit et al.196 and Loland et 
al.153 suggested the PASE to have acceptable measurement properties for assessing 
physical activity level in healthy elderly. Nevertheless, the use of self-reported tools to 
assess physical activity levels have been questioned, and the properties of the PASE had 
not been evaluated specifically for patients with hip OA. Hence, we decided to conduct a 
methodological study to evaluate both the test-retest reliability and the construct validity 
of the PASE in patients with clinical and radiographic hip OA. To evaluate construct 
validity we compared the PASE to the Actigraph GT1M accelerometer and the IPAQ, 
based on that they were considered to measure the same construct as the PASE. 
Accelerometers have been found to have acceptable criterion validity when compared to 
measures of free-living total energy expenditure measured by the doubly labelled water 
method, with correlation coefficient ranging from 0.56-0.8333, 83, 160, 189. Previous studies 
have reported correlation coefficients ranging from 0.29-0.55 between the IPAQ total 
MET-minutes per week and accelerometer measured counts per minute56, 94, 138, 155. 
 
The Norwegian version of the PASE153, which was used in this study, was a slightly 
adapted version. Due to cultural differences, i.e. the question on walking activities in the 
original version was removed, and walking activities were instead incorporated in the 
three questions which address light, moderate and vigorous activity. The rationale for 
this was, according to Loland et al.153, that walking activities is the most common form for 
physical activity in Norway. By removing one question and slightly transforming three 
others, the possible total achievable score was also influenced. Hence, the results of the 
Norwegian version of the PASE cannot easily be compared PASE results reported in 
foreign studies. 
 
Sample size and data analysis 
Post power calculations (90 % power and significance level of 5 %) was conducted for the 
outcome measures included in Paper I. Based on estimated MDCs for aggregated ROM109, 
isokinetic knee extension muscle strength148 and 6MWT117, 129, the number of patients 
needed in each group was calculated to be 66, 60, and 42-119, respectively. Based on the 
MCID for pain on VAS in patients with mild to moderate hip OA221, the estimated number 
needed in each group was estimated to be 80. Hence, we seem to lack power to detect 
possible significant group differences for these specific outcome measures. The certainty 
of these post power calculations can be questioned, due to lack of studies evaluating the 
MCID for hip ROM, isokinetic muscle strength and 6MWT in this specific patient group. 
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In the a priori sample size calculation based on the WOMAC pain subscale65 it was 
accounted for a 10 % drop-out rate. This estimate was close to the actual rate of patients 
who were lost to follow-up or declined participation at subsequent follow-ups. However, 
a larger proportion than we anticipated underwent THR and did not participate at 
subsequent follow-ups. Hence, the overall statistical power was reduced for the analyses 
of the self-reported outcome measures and the outcome measures of impairments and 
activity limitations. 
 
All analyses of efficacy in Paper I and Paper II were conducted according the ITT 
principle108, i.e. all patients were included in the analyses. The linear mixed model was 
used to compare treatment effect across the two groups over a 29 months follow-up 
period. It has been suggested to be less vulnerable to missing values than other models136. 
However, due to the relatively large amount of missing data caused by THRs, we 
suspected that missing was not at random. This was based on the assumption that THR is 
to be performed in cases of advanced disease; thus we expected the patient in our study 
who decided to undergo THR to have experienced a negative disease progression. The 
results of the missing value analysis (Paper I) confirmed that missing was not at random. 
This may have introduced bias to the between-group analyses of ROM, muscle strength, 
6MWT, pain during walking, WOMAC and PASE. Consequently, the long term mean 
estimates may have been slightly overestimated in both the exercise therapy group and 
the control group, as the supposedly poorer preoperative results of the patients who 
went through THR are missing. Furthermore, the between group difference in favour of 
the exercise group may have been underestimated as more patients in the control group 
had gone through THR. Because missing was considered to be not at random, we 
conducted a sensitivity analysis in Paper I by using the LOCF technique to evaluate the 
robustness of the results and to a greater extent account for the poorer preoperative 
performance of the patients who eventually underwent THR. The use of LOCF has been 
criticised, because it has been suggested to introduce bias176, 237. Other methods for 
imputation of missing values have been suggested237, but no general accepted imputation 
method exist when ‘missing not at random’ is the case. Wood et al236 stated that the 
choice of model is dependent on an understanding of the context. Thus, in this specific 
setting, where many patients had missing data due to THR, we considered the LOCF to be 
an alternative for evaluating preoperative group differences. Another possibility would 
have been to perform a strict ITT analysis, with all patients attending all follow-ups 
regardless of their choice of having a THR or not during the follow-up period. However, 
patients undergoing THR might still have biased the evaluation of the treatment effect, 
because more patients in the control group underwent THR.  
 
Based on the sample size in previous studies evaluating measurement properties of 
physical activity questionnaires, and after consulting a statistician, we decided to include 
40 patients in the reliability and validity study of the PASE. Sample size calculations in 
reliability and validity studies are rarely performed, since the objective of these studies is 
to calculate an estimate rather than to test a specific hypothesis. Terwee et al.213 
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suggested a sample size of at least 50 subjects to be adequate in studies evaluating 
measurement properties of physical activity questionnaires. Furthermore, inclusion of 
30-50 subjects has been considered adequate to enable data for calculating MDC147. 
Several models for calculation of the ICC exists200. The two-way model was chosen 
because it enabled us to include two or more covariates (patients and test occasions). 
Furthermore, the ‘absolute agreement’ was used to include the variance of each measure 
when evaluating the degree of correlation, instead of excluding systematic measurement 
errors. The SEM, MDC and LoA were calculated to provide information about the 
precision of the measure expressed in its specific unit of measurement. To evaluate the 
construct validity of the PASE, we compiled a priory hypotheses as suggested by Mokkink 
et al.164, defining the expected direction and magnitude of the correlations.  
 
Results  
 
Paper I and II 
In line with our findings, Juhakoski et al.124 found that exercise therapy had no significant 
short-term or long-term effect on hip ROM, lower limb muscle strength, or distance 
covered during the 6MWT124. Furthermore, no effect of exercise has been found in other 
walk tests or stair walk tests79, 124, 209 In contrast, French et al.79 demonstrated that 
patients who were given exercise therapy achieved better aggregated ROM compared to a 
control group. The post power calculations combined with the large amount of missing 
observations suggest that the study was underpowered to detect long-term group 
differences. However, the estimated between group differences in our study were small at 
all follow-ups. Relatively small deficits were present at baseline for both ROM, muscle 
strength, and walking capacity when compared to healthy controls and normative data13, 
14, 29, 31, 41, 85, 122, 195, 204, 218. Thus, the potential for improvement in these outcome measures 
may have been somewhat limited. Also, the patients in this trial had activity levels 
superior to what have been reported in other studies in patients with OA, more 
comparable to healthy individuals. This may indicate that relatively large doses of 
exercise would be necessary to alter their clinical impairments and functional 
performance. Furthermore, the lack of effect in isokinetic muscle strength may have been 
due to inadequate frequency and intensity of the strengthening exercises, below the 
suggested requirements for muscle strength increase133, 205 .  
 
Additionally, the relatively small impairments of the patients included in this trial may 
play a negligible role in the patients’ self-perceived functional level. Johnson et al.119 
found that significant improvement in WOMAC pain and physical function was not 
accompanied by similar improvements in ROM, disease activity and radiographic findings. 
The discrepancy between self-reported and observer-based measures was suggested to 
be related to the patients’ adaptations to living with a chronic disease120, but may also 
suggest that self-reported outcome measures are more responsive to changes over time. 
It is important to emphasise that neither of the groups in our study demonstrated a 
decline in mean results over the 29 month follow-up period. In patients with manifest 
52 
 
symptomatic hip OA a mean decline over time would have been expected. Consequently, a 
comparison with a true control group which received no treatment might have revealed a 
treatment effect over time for both our exercise therapy group and our control group.  
 
The beneficial pain relief during walking found in the exercise therapy group over the 29 
month follow-up period in our study was not accompanied by a significant better 
WOMAC pain score, in which three of five questions address resting pain. These results 
suggest that exercise therapy may influence activity related pain to a larger extent than 
resting pain in patients with hip OA with mild to moderate pain and symptoms. 
Furthermore, this can be related to the demonstrated effect in WOMAC physical function 
in the exercise therapy group, as activity related pain is suggested to influence self-
reported function207. The functional exercises included in the exercise program was 
based on previously reported ADL difficulties in patients with OA64. This task-specificity 
may have been decisive for the effect in self-reported physical function which was evident 
in the exercise group after 16 months65 and 29 months (Paper II). When we consider the 
beneficial effects for WOMAC physical function and pain during walking in relation to the 
demonstrated reduced risk for THR, it may suggests that activity related pain and the 
perceived ability of the patients to perform ADL without difficulty is important when 
deciding on whether and when THR is to be performed. The previously suggested 
estimated MCIDs for WOMAC physical function and VAS for pain in patients with hip OA 
with less severe hip OA, suggest that the demonstrated effect in these outcome measures 
at the ten, 16 and 29 months follow-up in our study may be clinically meaningful. 
Juhakoski et al.124 and French et al.79 found, in line with our results, a beneficial effect of 
exercise therapy on WOMAC physical function, but no significant effect on WOMAC pain, 
while Tak et al.209 demonstrated less pain and better score in the clinician-rated HHS.  
 
It has been suggested that that the largest treatment effect is present immediately after 
completion of an exercise intervention, with a decline in treatment effect over time42, 183. 
However, we demonstrated a beneficial effect of exercise therapy on WOMAC physical 
function and pain on VAS over a 29 months period, and Juhakoski et al.124 found a 
significant effect on WOMAC physical function after 18 months in favour of the exercise 
group. Furthermore, we found that exercise therapy reduced the 6-year risk for THR by 
44 %. This was supported by the findings in the study by Pisters et al.180, who 
demonstrated a reduced 5-year risk for surgery after individualised exercise treatment in 
patients presenting with clinical diagnose of hip OA. The beneficial long-term effects in 
the exercise therapy group may be a result of continuation of the exercise therapy 
program beyond the 12 weeks exercise period. Long-term adherence to exercise seems to 
be required to sustain its beneficial effect182, and higher leisure-time physical activity 
may also have a protective effect against THR2. Unfortunately, we did not obtain data on 
continuation of exercising in accordance with the exercise therapy program after the end 
of the 12-week exercise intervention period, but the data on exercise frequency and 
physical activity level did not differ between the two groups over the 29 month follow-up 
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period. However, these data should be interpreted with caution, as the main finding in 
Paper III was that the PASE lack validity to measure level and intensity of physical activity.  
 
The mechanisms for the beneficial effect of exercise in OA are poorly understood. Most 
research within this field is restricted to patients with knee OA, or a combination of knee 
and hip OA. Beckwee et al.16 have identified factors related to body impairments, activity 
limitations and general fitness, factors within the joint and in the surrounding tissue, and 
psychosocial factors as potential mechanisms which may explain the exercise induced 
improvements in pain and function in patients with knee OA. In patients with impaired 
ROM and muscle strength, improvements in these underlying factors may be beneficial, 
since ROM and muscle strength have been found to be associated with self-perceived 
function in hip OA13, 14, 195. The studies by French et al,78 and Hoeksma et al.107 both found 
that improvements in hip ROM were accompanied by improvements in self-reported 
outcome measures. Furthermore, it is suggested that exercise treatment may serve as a 
disease-modifier by inducing beneficial structural, biochemical and anti-inflammatory 
effects. These potentially positive effects of exercise on joint health might be relevant for 
disease deceleration and associated with improvements in pain and function. Still, only a 
limited number of studies have explored its effect on cartilage health and other intra-
articular factors related to OA progression, all concerning the knee joint102, 163, 188, 192, 222. 
Psychosocial factors, including pain coping and self-efficacy, are considered as important 
for the ability of each individual to adjust to and manage a painful, chronic disease. Hence, 
positive changes in these factors may contribute to the beneficial effect of exercise 
therapy in OA. Patients with OA who report high levels of self-efficacy are more likely to 
have less pain and functional impairments154.  Furthermore, self-efficacy has been 
identified as a mediator for the relationship between pain catastrophising and physical 
disability199, 202. Exercise may also influent OA symptoms by enhancing general well-being 
and reducing depression, and the placebo effect may be considerable in interventions 
including exercise treatment16. Furthermore, positive experiences with patient 
information and exercise may affect the patients’ preferred choice of treatment.  
 
Total hip replacement surgery is undoubtedly a good treatment option in cases of 
advanced hip OA. However, as the number of primary THRs have increased substantially 
the last decades137, concern has been raised because they will result in a greater number 
of patients experiencing surgical complications and, subsequently, an increase in future 
revisions84. According to the Norwegian Arthroplasty Register the relative number of 
revisions increase even more than the number of primary THRs167, 168. Of a random 
selection of 700 orthopaedic complaints reported to the Norwegian System of 
Compensation to Patients between 1993 and 1999, most complaints were referring to 
primary THRs due to hip OA22. Mechanisms delimiting the future THR and revision 
burden are highly requested84, 137, and include both consensus regarding criteria for THR 
and interventions potentially slowing down disease progression or improving the ability 
of the patients to cope with the disease. According to our findings, exercise therapy may 
represent a safe and easily administered treatment modality, with few complications, 
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which potentially can reduce the burden of THR. However, it has been debated whether 
postponing surgery is beneficial for the patients in the long-term71, 226, as preoperative 
status has been associated with postoperative outcome. Interestingly, some studies have 
found better postoperative results in patients with less pain and functional limitations 
prior to surgery172, 230, whereas other find patients with poorer preoperative outcome to 
experience larger post-operative improvements100, 123, 230. Additionally, Wang et al.229 and 
Gilbey et al.86 found that preoperative exercise improved post-operative physical function. 
These findings suggest that postponing surgery is safe if the preoperative condition 
remains stable or improves. It seems as if a treatment window exists in less severe 
disease where exercise therapy can be beneficial. Thus, in patients who are presenting 
acceptable pain and functional limitations, and who are able to participate in desired 
activities and social events, we consider postponing surgery to be appropriate, as it may 
reduce the future need for THR or additional THR revision surgery, and its accompanying 
potential for complications.  
 
Paper III 
In paper III we found the PASE to have acceptable test-retest reliability with an ICC of 
0.77 for the total score, based on that an ICC above 0.70 has been considered to represent 
acceptable reliability70, 213. However, the estimated measurement error was relatively 
large, with a MDC of 87, meaning that a change in total PASE score would have to exceed 
87 to represent a true change larger than the measurement error. Studies evaluating the 
test-retest reliability of the PASE in the general elderly population have reported ICC 
values ranging from 0.65 to 0.8192, 170, 225, 234.  
 
The construct validity of the PASE was considered to poor, as the correlation coefficient 
between the PASE and the Actigraph GT1M did not exceed the cut-off for acceptable 
validity. Perfect correlation between self-reported physical activity level and objectively 
measures of activity is unlikely213, and Lee et al.144 concluded that a correlation of 0.3–0.4 
is perhaps as close as can be expected when comparing these instruments. Washburn233 
found a relatively high correlation of 0.49 between the PASE score and an accelerometer. 
However, other studies have reported a correlation between the PASE and accelerometry 
of 0.1693, 150, more in line with our findings. The validity of the PASE has also been 
evaluated by comparing it to total energy expenditure calculated by the doubly labelled 
water method, giving correlation coefficients of 0.20 and 0.6833, 196. However, none of 
these previous studies have evaluated the validity of the PASE in patients with OA. 
Furthermore, it has not been evaluated if the PASE can provide reliable and valid data for 
physical activity intensity. However, our results indicated that the different intensity 
items of the PASE had poor construct validity and test-retest reliability. 
 
A possible reason for the discrepancy we and others have found between the PASE and 
the Actigraph GT1M may be that questionnaires seem to over-report physical activity56, 94, 
while accelerometers on the other hand have been found to under-report activity 
compared to the doubly labelled water method145. Problems with over-reporting when 
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using self-administered questionnaires can be related to recall bias and difficulties in 
evaluating true intensity level. Dyrstad et al.56 found that over-reporting physical activity 
was more common in men and in less educated subjects. Problems with under-reporting 
physical activity by accelerometry may be related to its limitations. Accelerometers are 
unable to capture activities like cycling and upper limb exercise, cannot be used to 
measure swimming and other water activities, and can only provide measurements for 
the particular time it is worn. Four days of registration210 with a minimum wear time of 
13 hours per day104 seems to be required to provide valid measures of physical activity. 
Hence, we consider our results to be valid, with a mean of 15 hours of registration per 
day over a mean of seven days. 
 
In the RCT the PASE was included to assess overall activity level at repeated follow-ups. 
Unfortunately, despite having acceptable reliability, the PASE fails to validly measure 
amount and intensity of physical activity in patients with hip OA with mild to moderate 
symptoms. Hence, the estimated PASE results and between group differences reported in 
Paper I and II must be interpreted with caution. Kayes and McPherson126 points out that 
both self-reported and objective measures of physical activity have limitations, but 
because they are likely to measure slightly different aspects of physical activity combined 
use of both methods can be useful. According to Ainsworth et al.3 questionnaires are 
suitable to measure physical activity in most settings, and have further suggested the use 
of a conceptual framework to improve accuracy of estimates derived from physical 
activity questionnaires4. In contrast, Trost et al.220 emphasises the advantages of the 
objective measures of physical activities and its appropriateness for use in clinical 
settings.  
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CONCLUSIONS 
 
In this thesis the long-term effect of exercise therapy and patient education in patients 
with hip OA presenting with mild to moderate symptoms has been investigated. 
Additionally, the measurement properties of a questionnaire, PASE, assessing physical 
activity level have been evaluated. Since few RCTs has been conducted in this field, the 
study is considered to add new and important knowledge with respect to long-term 
results after non-surgical, active treatment modalities evaluated by different outcome 
measures in hip OA. The following conclusions can be drawn: 
 
I.  Patients presenting with mild to moderate hip OA who were given a 12 week exercise 
program and a patient education program reported significantly less pain during 
walking over the 29 months follow-up period compared to patients who were given 
patient education only. However, exercise therapy in addition to patient education 
provided no benefit over patient education only evaluated by hip ROM, muscle 
strength or walking capacity.  
 
II. The 6-year survival of the native hip to THR was significantly higher in patients with 
mild to moderate hip OA who participated in a 12 week exercise therapy program 
and patient educations compared to patients who participated in patient education 
only, suggesting that exercise may reduce or postpone the need for THR. 
 
III.  Patients with mild to moderate hip OA who were given both exercise therapy and 
patient education had significantly better self-reported physical function, evaluated 
by WOMAC physical function, compared to patients who were given patient 
education only. No group differences were found for WOMAC pain or WOMAC 
stiffness. 
 
IV.  The PASE was found to have moderate test-retest reliability with an acceptable ICC-
value, but with large measurement error. The PASE was not considered to provide 
valid measures for overall physical activity level and specific physical activity 
intensities in patients with mild to moderate hip OA, based on its poor correlation 
with an accelerometer. 
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FUTURE PERSPECTIVES 
 
x More high quality RCTs evaluating the effect of exercise treatment are needed to 
increase the level of evidence for these modalities in patients with hip OA 
 
x Future studies should be aiming to identify specific exercise components which are 
particularly effective in hip OA 
 
x Studies evaluating the effect of exercise treatment should also 
x explore potential mechanisms for its beneficial effect, including mechanical 
factors, systemic factors, factors related to body function and impairments, 
and psychological factors 
x study treatment effect in specific sub-groups of patients with hip OA 
x identify patients who are most likely to benefit from exercise interventions 
 
x There is need for future studies to confirm that exercise therapy may postpone the 
need for THR 
 
x Effort should be made to reach general consensus on criteria for THR 
 
x The development of easy, valid and reliable methods for assessing physical activity 
and adherence to exercise interventions is highly encouraged. The use of 
accelerometry should be considered in clinical trials where valid data on physical 
activity is required. 
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ABSTRACT
Background Exercise treatment is recommended for all
patients with hip osteoarthritis (OA), but its effect on the
long-term need for total hip replacement (THR) is
unknown.
Methods We conducted a long-term follow-up of a
randomised trial investigating the efﬁcacy of exercise
therapy and patient education versus patient education
only on the 6-year cumulative survival of the native hip
to THR in 109 patients with symptomatic and
radiographic hip OA. Results regarding the primary
outcome measure of the trial, self-reported pain at
16 months follow-up, have been reported previously.
Results There were no group differences at baseline.
The response rate at follow-up was 94%. 22 patients in
the group receiving both exercise therapy and patient
education and 31 patients in the group receiving patient
education only underwent THR during the follow-up
period, giving a 6-year cumulative survival of the native
hip of 41% and 25%, respectively (p=0.034). The HR
for survival of the native hip was 0.56 (CI 0.32 to 0.96)
for the exercise therapy group compared with the control
group. Median time to THR was 5.4 and 3.5 years,
respectively. The exercise therapy group had better self-
reported hip function prior to THR or end of study, but
no signiﬁcant differences were found for pain and
stiffness.
Conclusions Our ﬁndings in this explanatory study
suggest that exercise therapy in addition to patient
education can reduce the need for THR by 44% in patients
with hip OA. ClinicalTrials.gov number NCT00319423
(original project protocol) and NCT01338532 (additional
protocol for long-term follow-up).
INTRODUCTION
Physical activity and patient information is recom-
mended for all patients with osteoarthritis (OA) of
the hip and knee as ﬁrst-line treatment. Total joint
replacement surgery is to be considered in cases of
advanced disease with severe pain and functional lim-
itations where other treatment options have failed.1 2
Exercise therapy is found to be beneﬁcial in reducing
pain and improving function in lower limb OA,3–6
but evidence for this is primarily based on studies
including patients with knee OA. In hip OA, exercise
interventions have shown promising results,7–9 but
the need for high-quality clinical trials with sufﬁcient
follow-up time is emphasised.3 4 6 Based on the
general consensus that total joint replacement surgery
is appropriate only in advanced stages of the disease,
joint replacement surgery may be used as an endpoint
to evaluate disease progression.10–14 It is unknown
whether exercise therapy can inﬂuence the progres-
sion of OA and thereby reduce the need for total
joint replacement.
The main objective of this study was therefore to
evaluate the long-term effect of exercise therapy in
addition to patient education on the patient’s need
for total hip replacement (THR). Our null hypoth-
esis was that there would be no difference in cumu-
lative survival of the native hip to THR in patients
with hip OA going through exercise therapy and
patient education compared with patient education
only.
METHODS
Study design and patients
This is a long-term follow-up of a randomised, con-
trolled trial evaluating the effect of exercise therapy
and patient education in patients with hip OA.9
Inclusion criteria were age between 40 and
80 years, hip pain for at least 3 months, radio-
graphically veriﬁed minimum joint space according
to Danielsson’s criterion15 (<4 mm for patients
<70 years, <3 mm for patients >70 years) and
Harris Hip Score between 60 and 95 points.16 In
patients with bilateral hip OA, the most painful hip
was deﬁned as the index joint. Night pain and
Harris Hip Score below 60 are used as criteria for
THR at our institution.9 Thus, the patients
included in the study were not candidates for THR
at the time of inclusion, and none of them were on
waiting lists for THR. Exclusion criteria were THR
in the index joint, knee pain or knee OA, low back
pain, rheumatoid arthritis, osteoporosis, cancer,
cardiovascular disease unable to tolerate exercise,
dysfunction in lower extremities due to accident or
disease, pregnancy and not understanding
Norwegian. Patient recruitment and screening for
inclusion has been described previously, together
with the results of the primary outcome measure
for this trial.9
Randomisation and treatment groups
All included patients were given three group ses-
sions of a patient education programme developed
for patients with hip OA.17 Thereafter they were
randomised to either an exercise therapy group or
a control group.9 A computer-generated randomisa-
tion list (block length 10, allocation ratio 1:1) was
conducted by a statistician prior to inclusion.
Sequentially numbered, sealed envelopes were used
to assign treatment for patients consecutively by a
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research coordinator not involved in the patient assessment or
interventions. Allocation concealment was maintained until
written informed consent was obtained, and baseline assess-
ments and patient education sessions were completed. The ran-
domisation sequence was concealed from the study
collaborators until treatment was assigned. The exercise therapy
programme was speciﬁcally designed for patients with hip OA18
and consisted of strengthening, ﬂexibility and functional exer-
cises. Patients in the exercise therapy group performed the exer-
cise programme two to three times per week for 12 weeks,
supervised by a physical therapist at least once weekly.
Compliance was based on training diaries ﬁlled in weekly by the
patients in the exercise therapy group during the 12-week inter-
vention period. Attending at least 20 of a total of 24 sessions
was deﬁned as satisfactory adherence. Patients in the control
group attended a 2-month follow-up visit at the physiotherapy
clinic as part of the patient education programme. They did not
have access to the exercise therapy programme during the inter-
vention period.
Outcome measures and follow-up
Characteristics of the patients’ included age, gender, height,
weight, work status, education level, unilateral or bilateral hip
pain, pain duration, minimum joint space and Harris Hip Score.
The main outcome measure for this long-term follow-up was
survival of the native hip to THR in the index joint. At inclusion all
patients were instructed to report if and when they went through
THR surgery during the project period. Additionally, data on THR
were recorded at follow-ups 4, 10, 16 and 29 months after inclu-
sion and by contacting all patients by telephone in April and May
2011 (ﬁgure 1). The outcome assessor was blinded to group alloca-
tion. The mean time from inclusion till the end of study at 15 May
2011 was 4.8 years, ranging from 3.6 to 6.1 years.
The Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC)19 and the Physical Activity
Scale for the Elderly (PASE)20 were ﬁlled in at baseline and at
the 4-, 10-, 16- and 29-month follow-up. In this long-term
follow-up study, WOMAC was used to assess symptoms and
functional limitations prior to THR surgery or end of study.
PASE is a brief, self-administered, 7-day recall questionnaire to
assess physical activity in older adults. The Norwegian version
was used, which consisted of 24 questions giving a total score
ranging from 0 to 315.21 Data on training sessions per week
were collected at baseline and at 4 months, data on engagement
in strength training and ﬂexibility training were collected at 16
and 29 months, and data on physical therapy treatment were
collected at 10, 16 and 29 months.
Statistical analysis
Patients were followed until time of THR in the index joint or
until death, drop-out or end of study. A Kaplan–Meier survival
analysis was constructed to evaluate cumulative 6-year survival,
and group difference was tested by the log rank test. THR in the
index joint was deﬁned as event, while patients who were lost to
follow-up, were dead or were followed until the end of study
were treated as censored in the analysis. Time to THR is reported
as median and 95% CI. A Cox proportional hazard model was
used to calculate HR and 95% CI between groups. No adjusted
analysis was conducted due to equality of groups at baseline.
Baseline comparisons were performed with Student t tests and χ2
tests. A linear mixed model (variance component model), with
time and the interaction of time and group as ﬁxed effects and
time as random effect intercept and slope, was used to compare
WOMAC scores between the exercise therapy group and the
control group over the 29-month follow-up period. A linear
mixed model was also applied to compare WOMAC scores prior
to THR surgery or end of study between patients who went
through THR and patients who did not. The analyses were based
on the intention to treat principle. For the outcome measures of
physical activity and exercise, mean (SD) or number was calcu-
lated, and a linear mixed model was used to compare PASE
scores between the exercise therapy group and the control group.
p Values below 0.05 were considered statistically signiﬁcant.
Analyses were performed by IBM SPSS Statistics, V.19.0 (IBM
Corp., Somers, New York, USA).
RESULTS
Characteristics of the patients
Two hundred and twenty patients were screened for eligibility
between April 2005 and October 2007. One hundred and nine
patients were included in the trial and randomised to the exer-
cise therapy group or the control group (ﬁgure 1). Baseline data
were similar in the two intervention groups (table 1). The
patients completed a median of 20 (IQR 16–24) exercise ses-
sions over the 12-week period, with 53% completing ≥20 exer-
cise sessions. One patient discontinued exercise after three
sessions due to increasing hip pain. No other adverse events
were registered.
Data on whether THR had been performed were obtained
from 102 patients. One patient died and was treated as censored
at the time of death. The remaining six patients were treated as
censored at the time of last follow-up or contact during the
follow-up period. Patients who were censored before the end of
study did not differ at baseline from those attending the long-
term follow-up.
A total of 41 patients in the exercise therapy group and 30
patients in the control group completed WOMAC at the
29-month follow-up (ﬁgure 1). Also, 27 patients had gone
through THR prior to the 29-month follow-up and 11 patients
were lost to follow-up at the 29-month follow-up.
THRs and cumulative survival of native hip
A total of –22 patients in the exercise therapy group and 31
patients in the control group went through THR within the 3.6–
6.1 years follow-up period. Estimated median time to THR was
5.4 (CI 4.5 to 6.2) years in the exercise therapy group and 3.5 (CI
2.3 to 4.6) years in the control group. The Kaplan–Maier analysis
showed that the cumulative 6-year survival of the native hip to
THR was 0.41 in the exercise therapy group compared with 0.25
in the control group (p=0.034) (ﬁgure 2). Cox proportional
hazard analysis showed that participating in both exercise therapy
and patient education had a protective effect against THR com-
pared with patient education only (HR=0.56, CI 0.32 to 0.96,
p=0.036). Thirty-ﬁve per cent of the patients went through THR
surgery at the Oslo University Hospital, and the remaining 65%
went through surgery at 1 of 11 other hospitals in the southern
parts of Norway. None of the non-operated patients reported to
be on waiting list for THR at the end of study.
Self-reported pain, stiffness and function
Over the 29-month WOMAC follow-up period, the exercise
therapy group had signiﬁcantly better WOMAC physical func-
tion scores compared with the control group (p=0.004), but
the between-group differences in the WOMAC pain (p=0.083)
and WOMAC stiffness (p=0.112) scores did not reach statistical
signiﬁcance (table 2).
Mean minimum joint space at baseline was 1.5±0.9 mm in
patients who went through THR compared with 2.5±1.0 mm
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in the patients who did not (p<0.01). At baseline there were no
signiﬁcant differences between patients who went through THR
and patients who did not in neither WOMAC pain (p=0.967),
WOMAC stiffness (p=0.333) nor WOMAC physical function
(p=0.092). The 53 patients who underwent THR before the
end of study had worse preoperative score in all WOMAC sub-
scales over the 29-month WOMAC follow-up period compared
with the patients who did not go through THR or were cen-
sored at the end of study (p<0.01) (table 2).
Self-reported physical activity and exercise
The number of self-reported exercise sessions per week was
similar in the two groups. At the 16-month follow-up, 75
patients replied to the questions on exercise and physical
Figure 1 Enrolment, randomisation and follow-up of patients.
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therapy, and at the 29-month follow-up 70 patients replied
(table 3). There was no signiﬁcant difference in PASE scores
between the exercise therapy group and the control group over
the 29-month follow-up period (p=0.397).
DISCUSSION
Participating in both exercise therapy and patient education
resulted in signiﬁcantly higher 6-year cumulative survival of the
native hip to THR compared with patient education only. Thus,
the null hypothesis was rejected. The cumulative survival of the
native hip was higher in the exercise therapy group from 1 year
and throughout the follow-up period.
This is the ﬁrst study to evaluate whether exercise therapy
affects the need for THR in patients with isolated hip OA. One
previous study has used total joint replacement as an outcome
to compare the effect of individually tailored exercises and
usual care in knee and/or hip OA.22 They found that 20%
underwent THR in the individually tailored exercise therapy
group compared with 45% in the usual care group for those
with hip OA. The probability for THR within 5 years was 2.87
(95% CI 1.1 to 7.3) times higher in the usual care group.22 In
our study, 40% in the exercise therapy group and 57% in the
control group underwent THR, with the control group having
1.80 times higher probability of THR. The somewhat smaller
protective effect of exercise in our study may be due to the
patients having both symptomatic and radiographic hip OA.
Pisters et al22 based inclusion on the clinical criteria of the
American College of Rheumatology alone, which does not
include radiographic evidence of OA.
Previous studies have reported that 24–53% of patients with
symptomatic and radiographic hip OA undergo THR during
follow-up ranging from 14 months to 10 years.15 23 24 THR
rates have increased steadily during the past four decades,25
which in turn has enlarged healthcare costs substantially.26 Our
ﬁnding, that exercise therapy enhances the survival of the native
hip to THR, is therefore important for healthcare consumption
and for patients who may avoid surgery and its potential com-
plications. Some studies have recommended and used total joint
replacement as a hard endpoint in OA,10 27–29 but it is debatable
whether it can be interpreted as an expression for OA progres-
sion. Attempts are requested26 and have been made,30 but still
no clearly deﬁned criteria for THR exist. Worse self-reported
pain and functional limitations are associated with a higher
THR rate,31 but cannot be used to discriminate between
patients who are or are not in need of a THR as clinical severity
varies widely.30 32 In our study, the patients who went through
THR had poorer scores in the WOMAC subscales for pain, stiff-
ness and physical function prior to THR compared with the
patients who did not undergo THR. This supports the assump-
tion that the patients who undergo THR surgery have more
severe symptoms and functional limitations. Also, the patients
who went through THR had smaller minimum joint space at
baseline. Abadie et al13 stated that THR is probably the most
relevant clinical endpoint for evaluating effect of disease-
modifying treatment, but it is potentially biased by
non-disease-related factors such as economic factors, availability
and geographical differences, comorbidities and contraindica-
tions for surgery, and willingness to undergo surgery.12 13
However, in a randomised design study, equal distribution of
potential confounding factors is assumed.
Other studies have found beneﬁcial short-term effects of exer-
cise therapy.7 8 No signiﬁcant difference in self-reported pain
was demonstrated in the 16-month follow-up of our trial, but
the patients in the exercise therapy group had better self-
reported physical function compared with the control group.9
This was supported by the ﬁndings in our study, with the exer-
cise therapy group demonstrating better results in WOMAC
Table 1 Baseline characteristics of the study patients*
Exercise therapy
group (n=55)
Control group
(n=54)
Age (years) 58.4±10.0 57.2±9.8
Female sex, no. (%) 31 (56.4) 28 (51.9)
Body mass index (kg/m2) 24.6±3.2 24.9±3.8
Minimum joint space in target
joint† (mm)
2.1±1.0 1.9±1.1
Pain duration (months) 47.3±53.3 49.5±50.9
Harris Hip Score‡ 79.6±7.7 76.9±8.2
Bilateral radiographic hip OA,
no. (%)
38 (69.1) 38 (70.3)
THR in contralateral hip at
inclusion, no. (%)
4 (7.3) 2 (3.7)
Hereditary OA/known OA in
family, no. (%)
17 (33.3) 21 (38.9)
>12 years of education, no. (%) 43 (78.2) 35 (67.3)
Work status
Employed, no. (%) 35 (63.6) 36 (66.7)
Sick leave, no. (%) 8 (14.5) 5 (9.3)
Retired, no. (%) 12 (21.8) 9 (16.7)
WOMAC score§
Pain subscale 26.0±16.1 27.3±17.9
Stiffness subscale 34.8±23.7 34.3±20.5
Physical function subscale 21.1±15.3 23.6±15.7
*Plus-minus values are mean±SD. The body mass index is the weight in kilograms
divided by the square of the height in metres.
†The minimum joint space in the hip joint was assessed according to Danielsson’s
criterion.15 For patients older than 70 years, a minimum joint space below 3 mm was
characterised as radiographic hip OA. For patients younger than 70 years, a minimum
joint space below 4 mm was characterised as radiographic hip OA.
‡The Harris Hip Score is a clinician-administered tool to evaluate hip pain, hip
function and hip range of motion.16 An overall score is calculated ranging from 0 to
100, with a lower score indicating more severe disease.
§The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
comprise three subscales (pain, stiffness and physical function) composed of 24
questions. Scores range from 0 to 100, with a higher score indicating more severe
disease.19
OA, osteoarthritis; THR, total hip replacement.
Figure 2 Kaplan–Meier survival estimates over the 6-year follow-up
period. The black line represents the exercise therapy group, and the
grey line represents the control group. Censored data are marked at
each line. The number of patients at risk is given for each year for each
group.
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physical function compared with the control group over the
complete 29-month follow-up period (p=0.004), The differ-
ences in WOMAC pain (p=0.083) and WOMAC stiffness
(p=0.112) did not reach statistical signiﬁcance. This may indi-
cate that the lower rate and longer time to THR in the exercise
therapy group are due to better hip function, with or without
the presence of pain. Ten patients in the exercise therapy group
and 17 patients in the control group had gone through THR
surgery prior to the 29-month follow-up, and it is not unlikely
that this uneven distribution of performed THRs has biased the
WOMAC results, giving an underestimation of the treatment
effect of exercise therapy. Pisters et al22 found no long-term dif-
ferences in pain and function when comparing individually tai-
lored exercises and usual care, but suggested that patients who
underwent THR may have biased the results. Fifty-three per
cent of the patients in the exercise therapy group completed
≥20 exercise sessions and were thus regarded as compliant.
Data on continuation of the exercise therapy programme after
the 12-week intervention period were not obtained, and this
must be regarded as a limitation of the study. However, the data
on physical activity, exercise and physical therapy treatment
suggest that no major between-group differences were present.
Self-reported outcome measures lack validity for measuring
physical activity and exercise due to recall bias and overesti-
mation of time, frequency and intensity,33 and these data should
therefore be interpreted with caution. Better adherence to exer-
cises has been shown to improve long-term results,34 and higher
leisure time physical activity may have a protective effect against
THR.35
Our study had some limitations. The criteria for when THR
surgery was indicated were not speciﬁed prior to the start of the
study. The criteria used for THR at our institution (night pain and
Harris Hip Score below 60 points) are not necessarily used at other
hospitals, and the symptom state may differ at time of surgery.
Preoperative assessment was not conducted, but pain and physical
function were assessed with a mean time of 0.7±0.8 years prior to
THR. Calculation of statistical power for this study was not based
on survival of the native hip to THR, but rather the WOMAC pain
subscale, which was the primary outcome measure of this trial.9
Some caution should be taken when interpreting these results.
Our ﬁndings are applicable for patients with symptomatic and
radiographic hip OA, with mild to moderate symptoms. Patients
with severe symptoms and patients with knee or back pain were
excluded. Patients recruited to non-surgical treatment trials may
have a stronger desire to avoid surgery compared with the
general OA population.12 It is debatable whether postponing
Table 3 Self-reported physical activity in the exercise therapy group and the control group at baseline and at the 4-, 10-, 16- and 29-month
follow-up*
Baseline 4 months 10 months 16 months 29 months
Exercise therapy group
PASE score† 114±43.5 115±52.9 118±48.6 123±50.7 120±46.8
Exercise sessions per week 3.2±2.0 3.7±1.9
Engaged in strength training—no 22 21
Engaged in flexibility training—no 29 27
Physical therapy treatment—no 14 16 14
Control group
PASE score† 123±50.6 121±45.4 126±57.3 133±57.3 139±59.2
Exercise sessions per week 3.2±2.1 3.7±2.0
Engaged in strength training—no 24 18
Engaged in flexibility training—no 25 22
Physical therapy treatment—no 18 13 20
*Plus-minus values are mean±SD.
†The Physical Activity Scale for the Elderly (PASE) consists of 24 questions on physical activity and the total score expresses the overall physical activity level. Scores range from 0 to
315, with 0 indicating complete inactivity and 315 indicating extremely high level of activity.20 21
Table 2 Difference in self-reported pain, stiffness and function at baseline and at the 4-, 10-, 16- and 29-month follow-up between the
exercise therapy group and the control group, and between the patients who went through THR surgery and the patients who did not*
Baseline 4 months 10 months 16 months 29 months
Mean difference (95% CI) between the exercise therapy group and the control group
WOMAC†
Pain −1.3 (−8.0 to 5.3) −4.7 (−11.4 to 1.9) −6.6 (−13.9 to 0.8) −6.5 (−14.3 to 1.3) −5.9 (−14.2 to 2.4)
Stiffness 0.5 (−8.0 to 9.1) −3.5 (−12.0 to 5.0) −6.3 (−15.8 to 3.2) −12.5 (−22.5 to −2.5) −3.9 (−14.6 to 6.7)
Physical function −2.5 (−8.7 to 3.7) −4.6 (−10.7 to 1.6) −8.4 (−15.2 to −1.6) −9.2 (−16.5 to −1.9) −6.4 (−14.1 to −1.3)
Mean difference (95% CI) between the patients who underwent THR‡ (n=53) and the patients who did not (n=56)
WOMAC†
Pain 0.1 (−6.4 to 6.7) 5.6 (−0.9 to 12.1) 11.9 (4.7 to 19.1) 9.3 (1.5 to 17.1) 13.2 (4.6 to 21.8)
Stiffness 4.1 (−4.3 to 12.5) 9.5 (1.1 to 17.8) 10.6 (1.3 to 19.9) 15.2 (5.2 to 25.2) 12.7 (1.7 to 23.8)
Physical function 5.0 (−0.9 to 11.0) 8.9 (2.9 to 14.8) 11.9 (5.3 to 18.4) 13.3 (6.2 to 20.4) 15.1 (7.3 to 23.0)
*Plus-minus values are mean±SD.
†The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) comprise three subscales (pain, stiffness and physical function) composed of 24 questions. Scores range
from 0 to 100, with a higher score indicating more severe disease.19
‡Results for patients who went through THR are preoperative results up until time of surgery.
THR, total hip replacement.
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surgery is beneﬁcial for the patients in the long term.36 37 We
argue that for patients with tolerable pain who are able to main-
tain their desired activity level and who are relatively young
postponing surgery is appropriate and may reduce the future
need for THR or repetitive THR revision surgery.
CONCLUSIONS
Our ﬁndings in this explanatory study show that participating in
a 12-week exercise therapy programme in addition to patient
education can reduce the need for THR or postpone surgery in
patients with hip OA. This supports the recommendations
stating that exercise therapy should be offered to patients with
hip OA as ﬁrst-line treatment.
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Reliability and validity of the Physical Activity
Scale for the Elderly (PASE) in patients with hip
osteoarthritis
Ida Svege1*†, Elin Kolle2† and May Arna Risberg1,2†
Abstract
Background: Physical activity (PA) is beneficial in reducing pain and improving function in lower limb
osteoarthritis (OA), and is recommended as a first line treatment. Self-administered questionnaires are used to
assess PA, but knowledge about reliability and validity of these PA questionnaires are limited, in particular for
patients with OA. The purpose of this study was to evaluate the reliability and validity of the Physical Activity Scale
for the Elderly (PASE) in patients with hip OA.
Methods: Forty patients with hip OA (20 men and 20 women, mean age 61.3 ± 10 years) were included. For test-
retest reliability PASE was administered twice with a mean time between tests of 9 ± 4 days. Intraclass correlation
coefficient (ICC), standard error of measurement (SEM) and minimal detectable change (MDC) were calculated for
the total score and for the particular items assessing different PA intensity levels. In addition a Bland-Altman
analysis for the total PASE score was performed. Construct validity was evaluated by comparing the PASE results
with the Actigraph GT1M accelerometer and the International Physical Activity Questionnaire (IPAQ), using the
Spearman rank correlation coefficient.
Results: ICC for the total PASE score was 0.78, with relatively large error of measurement; SEM = 31 and MDC =
87. ICC for the intensity items was 0.20 for moderate PA intensity, 0.46 for light PA intensity and to 0.68 for
vigorous PA intensity. The Spearman rank correlation coefficient between the Actigraph GT1M total counts per
minute and the total PASE score was 0.30 (p = 0.089), and ranging from 0.20-0.38 for the different PA intensity
categories. The Spearman rank correlation between IPAQ and PASE was 0.61 (p = 0.001) for the total scores.
Conclusions: In patients with hip OA the test-retest reliability of the total PASE score was moderate, with
acceptable ICC, but with large measurement errors. The construct validity of the PASE was poor when compared
to the Actigraph GT1M accelerometer. Test-retest reliability and construct validity revealed that the PASE was
unable to assess PA intensity levels. PASE is not recommended as a valid tool to examine PA level for patients with
hip OA.
Background
Physical inactivity is considered to be a risk factor for
many life-threatening diseases and regarded as a major
burden on general public health, therefore international
and national guidelines recommend that all adults
engage in moderate to vigorous physical activity
(MVPA) for at least 30 minutes per day[1-3]. Patients
with OA are found to be less physically active than the
general adult population, and fewer fulfill the recom-
mendations of 30 minutes MVPA per day[4,5]. Being
physically active according to the recommended guide-
lines is beneficial in preserving function and reduce
symptoms[6], and PA is recommended as a first line
treatment that should be offered to all individuals with
hip or knee OA[7,8]. The efficacy and importance of PA
and exercise for patients with OA of the lower limbs
have been emphasized in several studies[9-12].
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Valid and reliable methods for PA assessment are
essential for studying its health effects. Frequency, dura-
tion and intensity are important factors when evaluating
PA as a protective factor against OA progression and
functional decline[13]. Numerous methods for assessing
PA are available, and can be categorized into three main
groups; self-reported assessments (questionnaires, rating
scales, diaries), activity monitors (accelerometers, ped-
ometers, heart rate monitors) and direct assessment of
energy expenditure (doubly labelled water, indirect
calorimetry). Self-administered questionnaires, including
the Physical Activity Scale for the Elderly (PASE), can
potentially capture all types of activities and allow grad-
ing by intensity. They are widely used, due to being
inexpensive and easy to administer, and are considered
particularly useful in large epidemiological and longitu-
dinal studies. However, questionnaires have obvious
weaknesses considering recall and reporting bias. In
contrast, accelerometers offer a method for measuring
body acceleration, and thereby quantify amount and
intensity of movement[14]. Accelerometers often serve
as a comparator when validity of questionnaires is evalu-
ated, as they are expected to measure the same con-
struct[15].
Despite the fact that many self-administered question-
naires are available, evidence for validity and reliability
is limited [13]. PASE has been found to significantly
correlate in expected directions with physical perfor-
mance, knee pain and knee functioning in patients with
knee pain[6,16], and previous studies have reported cor-
relation coefficients of 0.16, 0.43 and 0.49 when com-
pared to an accelerometer in the general, elderly
population[17-19]. However, the validity of PASE has
not been evaluated in patients with hip OA by compar-
ing it to an accelerometer. The purpose of this study
was therefore to evaluate the construct validity and the
test-retest reliability of the Norwegian version of the
Physical Activity Scale for the Elderly (PASE) in patients
with hip OA.
Methods
Subjects
Forty patients with hip OA from a larger ongoing ran-
domized controlled trial (RCT), evaluating the effect of
patient education and supervised exercise in patients
with hip OA[20], were included. Inclusion criteria were
age between 40 and 80 years, uni- or bilateral hip pain
for more than three months, Harris Hip Score[21]
between 60 and 95, and radiographically verified hip OA
according to Danielsson’s criteria[22]. Patients with low
back pain or knee pain, trauma or functional impair-
ments, or diseases that might interfere with participation
were excluded. Patients who had gone through total hip
replacement surgery (THR) since inclusion in the RCT
were also excluded. During September 2010, 61 patients
who had been included in the original RCT between
2006 and 2008, were re-contacted and requested to par-
ticipate in this validation study. Twelve patients did not
respond, eight had gone through THR surgery and one
lived abroad. The remaining 40 patients agreed to parti-
cipation and were included in the study.
Anthropometrical (age, gender, height, weight) and
sociodemographic data (work status, educational level),
as well as data on Harris Hip Score, minimal joint space
width, bilateral hip pain and pain duration was recorded
at time of inclusion in the original RCT. Data on age
has been altered to reflect the actual age at the time of
data collection in this validation study.
The study was approved by The Regional Committee
for Medical Research Ethics for South-Eastern Norway.
All participants received both oral and written informa-
tion and signed a written informed consent, before
inclusion. The data collection was carried out in accor-
dance with the directives given in the Declaration of
Helsinki.
Outcome measurements
PASE is a brief, self-administered, 7-day recall question-
naire designed to assess PA in older adults[23]. It has
also been used in studies assessing PA in patients with
OA[24,25]. In this study we used the Norwegian version
of the PASE, which was slightly adapted when translated
due to cultural differences[26], i.e. the question in the
original version addressing walking activities was incor-
porated in the three questions addressing light, moder-
ate and vigorous PA activity. It consists of 24 questions
in total and the overall PASE score ranges from 0-315
(and above). The instructions for use and scoring given
in the PASE Administration and Scoring Manual were
followed (http://www.neri.org). The questions included
in PASE address leisure-time, household and work-
related PA, with the different items weighted differently.
Participation in leisure-time PA, including light, moder-
ate and vigorous PA intensity, and strengthening activ-
ities, is recorded as never, seldom (1-2 days per week),
sometimes (3-4 days per week), and often (5-7 days per
week). Duration is categorized as less than 1 hour, 1-2
hours, 2-4 hours and more than 4 hours. Housework
activities are recorded as yes or no, and paid or unpaid
work, requiring some PA, is recorded in hours/week.
The total PASE score is computed by multiplying time
spent in each activity (hours per day) (for leisure and
work-related activities) or participation (yes/no) in an
activity (for household-related activities), by empirically
derived weighting, and then summarizing all items[26].
From the PASE recordings we calculated the total PASE
score, representing the overall activity level. In addition
we calculated the PASE score for household-/work-
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related activities and the PASE score for leisure-time
PA, as well as the PASE score from the items addressing
light, moderate and vigorous PA intensity.
Construct validity of the PASE was evaluated by com-
paring it to the Actigraph GT1M accelerometer (Acti-
Graph, LLC, Pensacola, FL, USA) and to the short form
of the International Physical Activity Questionnaire
(IPAQ). The Actigraph GT1M is an electronic motion
sensor comprising a single plane (vertical) accelerometer.
Movement in the vertical plane is detected as a combined
function of the frequency and intensity of the movement.
Counts are summed over 10 second epochs and down-
loaded to memory. All sequences of 60 minutes or more
of consecutive zero counts were excluded from each indi-
viduals recording. For the analyses, a valid day was
defined as having 10 or more hours of monitor wear. Six
or more valid days of registration were considered suffi-
cient. Accelerometers were initialized and downloaded
using the software program ActiLife (ActiGraph, LLC,
Pensacola, FL, US). Data were reduced using the SAS-
based software program (SAS Institute Inc., Cary, North
Carolina, USA) called CSA Analyzer (csa.svenssonsport.
dk). From the Actigraph GT1M registrations we calcu-
lated average counts per minute representing the overall
activity level. In addition we calculated total minutes
spent in 0-99 counts per minute, 100-2019 counts per
minute, 2020-5999 counts per minute and above 6000
counts per minute, representing minutes spent inactive,
and in light, moderate and vigorous PA intensity, respec-
tively[27,28]. The proportion of patients who achieved
the recommended 30 minutes of daily MVPA was estab-
lished by dividing total time in MVPA by the number of
valid days of recording, giving an average (minutes per
day) across the assessment period.
The development of the IPAQ was initiated in 1996,
and conducted by an International Consensus Group,
with the intention to develop a measure suitable for
assessing population levels of PA across countries[29].
IPAQ is a short, self-administered, 7-day recall question-
naire designed for assessing PA in adults. It consists of
seven questions which include PA in all contexts of
everyday life, and addresses days, hours and minutes
spent on vigorous PA, moderate PA and walking. A
question on sitting hours per day is also included. The
IPAQ is scored by using the Metabolic Equivalent of
Task (MET) method, where different activities and levels
of intensity are given different MET estimates. In this
study the Norwegian version of the IPAQ short form
was used, as well as instructions given in the IPAQ
Scoring Protocol, both described at http://www.ipaq.ki.
se. For the IPAQ we calculated the total MET-minutes
per week, representing the overall activity level. In addi-
tion we calculated MET-minutes per week for walking
activities, moderate activities and vigorous activities.
Procedures
Data collection for the evaluation of test-retest reliability
and construct validity was carried out during October
2010. The Actigraph GT1M was administered by postal
mail to all included patients, and it was worn in an elas-
tic belt placed on the right hip. All participants were
instructed to wear the accelerometer during all waking
hours, except during bathing and swimming, over a per-
iod of seven consecutive days (1th -7th day), se Figure 1.
The questionnaires, PASE and IPAQ, was administered
to the participants by mail on the 7th day, and filled in
on the 8th day, the day after finishing the accelerometry
registration period, and returned by mail. For evaluation
of test-retest reliability PASE was also filled out seven
days later (on the 15th day).
Analysis
Baseline characteristics and descriptive data for the Acti-
graph GT1M, the PASE and the IPAQ calculations are
presented as mean and standard deviation (SD) or num-
ber and percentage (%). To evaluate the test-retest relia-
bility for the total PASE score the intraclass correlation
coefficient (ICC2.1 - two-way random effect model, abso-
lute agreement) was calculated. In addition, ICC2.1 was
calculated for the sub-score for household/work-related
PA, the sub-score for leisure-time PA, and for the PASE
score of the items for light, moderate and vigorous PA
intensity. Measurement error was assessed by estimating
the standard error of measurement (SEM), minimal
detectable change (MDC) and limits of agreement
(LoA). SEM was calculated as the square root of the
within-subject total variance of an ANOVA analysis,
SEM = √vartot, and the MDC was calculated as MDC =
1.96 × √2 × SEM [30]. LoA were calculated according to
the Bland-Altman method and a Bland Altman plot for
visual judgment of the relationship between the indivi-
dual mean total PASE score of the test and retest, and
the difference in total PASE score between test and ret-
est was made[31].
The construct validity of the PASE was evaluated by
calculating the Spearmans rank correlation coefficients
(r) for the total PASE score and the Actigraph GT1M
(total counts per minute), and for the total PASE score
and the total IPAQ score (total MET-minutes per
week). A priori hypotheses were made based on pre-
vious studies comparing PA questionnaires and PA mea-
sured by accelerometry. As recommended by Terwee et
al.[15], the most similar constructs of the PASE and the
Actigraph GT1M were compared. We hypothesized a
low to moderate positive correlation (r between 0.15
and 0.5) between the total PASE score and the Acti-
graph GT1M counts per min. We hypothesized a mod-
erate to strong positive correlation (r between 0.6 and
0.9) between the total PASE score and the IPAQ total
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MET-minutes per week. Terwee et al.[15] suggested that
the correlation between a PA questionnaire (total score)
and accelerometry (counts per minute) should exceed
0.5. We therefore interpreted this as a cut-off for accep-
table validity.
In addition, Spearmans r were calculated for the
PASE items for light, moderate and vigorous PA inten-
sity and the different intensity levels/categories assessed
by the Actigraph GT1M and IPAQ. For these compari-
sons the approach was more explorative, but the PASE
score for the different intensity items were hypothesized
to correlate most strongly with the respective categories
of the Actigraph GT1M and the IPAQ as follows: 1) the
PASE light PA intensity with the Actigraph GT1M min-
utes of light PA intensity and the IPAQ walking MET-
minutes per week, 2) the PASE moderate PA intensity
with the Actigraph GT1M minutes of moderate PA
intensity and the IPAQ walking MET-minutes per week
and IPAQ moderate MET-minutes per week, and 3) the
PASE vigorous PA intensity with the Actigraph GT1M
minutes of vigorous PA intensity and the IPAQ vigorous
MET-minutes per week.
All statistical analyses were performed using the
PASW Statistics 18 for Windows (IBM Corporation,
Route, Somers, NY, USA).
Results
All 40 patients completed PASE at day 8, but at day 15
PASE were missing or inadequately filled out for seven
patients. Calculation of the test-retest reliability was
therefore based on the 33 patients with complete PASE
questionnaires both at test and retest. Thirty-six patients
had completed the Actigraph GT1M recording period
and had readable files. Two patients returned the Acti-
graph GT1M unused, and data from two patients were
not successfully downloaded. Six or more days of regis-
tration were considered to be sufficient. Three patients
had less than six days of registration and were thus
excluded from the analysis. In total, recordings from 33
patients were included to calculate correlation coeffi-
cients between the PASE and the Actigraph GT1M. The
average days of registration were 7.0 (0.6). For the
IPAQ, 15 patients had missing or incomplete question-
naires, leaving 25 patients to be included to calculate
correlation coefficients between the PASE and the
IPAQ. This was mainly due to inability to calculate the
IPAQ score because the response alternative “don’t
know” was chosen.
Demographic and clinical characteristics of the
patients are shown in Table 1. Based on the Actigraph
GT1M measurements 67% fulfilled the recommenda-
tions of at least 30 minutes of accumulated MVPA per
day, and 30% fulfilled the recommendations of at least
30 minutes of MVPA per day in blocks of minimum 10
minutes. At average the patients spent 45 (32) minutes
per day on MVPA.
Test-retest reliability
Mean days between test and retest was nine days (SD
4.0), ranging from six to 25 days. Mean PASE score at
test (n = 33) was 143 (SD 71) and at retest 125 (SD 56).
The decline in the total PASE score from test to retest
was significant (p = 0.02), but no significant differences
was revealed for any of the sub scores/items. ICC2.1 for
the total PASE score was 0.77, SEM was 31 and MDC
was 87 (Table 2). Test-retest values for the different sub
Figure 1 Schematic view of the timeline of the study. PASE: Physical Activity Scale for the Elderly; IPAQ: International Physical Activity
Questionnaire.
Table 1 Demographics and clinical characteristics of the
40 patients
Variables
Age in years, mean (SD) 61.3 (10.0)
Men, n (%) 20 (50)
Body mass index, kg/m2, mean (SD) 24.5 (3.6)
Years of education, n (%)
7-9 years 11 (28.2)
10-12 years 13 (33.3)
> 12 years 15 (38.5)
Work status, n (%)
At work 26 (66.7%)
Retired 10 (25.6%)
Sick-leave 3 (7.8%)
Bilateral hip-pain, n (%) 30 (75)
Minimal joint space in most painful hip, mm, mean (SD) 2.5 (0.9)
Pain duration, months, mean (SD) 49.8 (55.4)
Harris Hip Score, mean (SD) 80.7 (7.9)
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scores/items are also shown in Table 2. The Bland Alt-
man plot for the total PASE score is shown in Figure 2.
The lower LoA was -65 and the upper LoA was 100.
One out of 33 values (3%) was outside the LoA.
Construct validity
The Spearman’s rank correlation coefficient (r) between
the PASE score and the Actigraph GT1M, and the
PASE score and the IPAQ score is shown in Table 3.
The correlation between the total PASE score and the
Actigraph GT1M mean counts per minute was 0.30(p =
0.089). When comparing the total PASE score with the
IPAQ total MET-minutes per week the correlation coef-
ficient was 0.61 (p = 0.001).
For the different PA intensity items of the PASE we
expected higher correlation coefficients with the respec-
tive categories of the Actigraph and the IPAQ. These
comparisons are highlighted in Table 3. The correlation
coefficients ranged from 0.10 to 0.35 between PASE and
the Actigraph for the comparisons with the expected
highest correlation, with only the correlation between
the PASE item for moderate PA intensity and the
Table 2 Test-retest reliability of the PASE
PASE score Test, mean (SD) Retest, mean (SD) d, mean (95% CI) ICC2.1 (95% CI) SEM MDC
Total score (n = 33) 143 (71) 125 (56) 18 (-3,-32) 0.77 (0.56, 0.88) 31 87
Household/Work activities 114 (63) 84 (59) 15 (-1, 30) 0.69 (0.46, 0.84) 32 89
Leisure time PA 29 (24) 26 (19) 3 (-4, 10) 0.53 (0.24, 0.74) 15 40
Light PA intensity 13 (22) 10 (11) 3 (-4, 9) 0.46 (0.15, 0.69) 13 35
Moderate PA intensity 9 (10) 9 (13) 1 (-5, 6) 0.20 (-0.16, 0.51) 10 28
Vigorous PA intensity 4 (6) 5 (7) -1 (-2, 1) 0.68 (0.44, 0.83 4 10
PA physical activity, PASE Physical Activity Scale for the Elderly, d: difference between test and retest, ICC2.1 intraclass correlation coefficient, two-way random
effects ANOVA, SEM standard error of measurement, MDC minimal detectable change
Mean Total PASE Score, test and retest
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Figure 2 Bland-Altman plot for total PASE score. Intra-individual differences (n = 33) plotted against the difference between test and retest
scores for the total PASE score. The central horizontal line represents the mean difference, while the flanking lines represent the 95% limits of
agreement. The dotted line represents no difference between test and retest.
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respective Actigraph category reaching statistical signifi-
cance. The correlation coefficients ranged from 0.29 to
0.75 between PASE and IPAQ for the comparisons with
the expected highest correlation. Of these, the correla-
tion between the PASE score for moderate PA intensity
and the IPAQ score for walking, and the PASE score for
vigorous PA intensity and the IPAQ score for vigorous
PA intensity reached statistical significance.
Discussion
This is the first study to address the test-retest reliability
and the construct validity of the PASE in patients with
hip OA, and the first study to evaluate the validity of
the Norwegian version of the PASE. It is also one of
relatively few studies evaluating the construct validity of
a self-administered instrument for assessing PA by com-
paring it to an accelerometer, a method for direct mea-
surement of PA, in patients with OA[13].
In our study we found that 67% of patients with hip
OA fulfilled the recommendations of achieving at least
30 minutes of accumulated MVPA per day, but only
30% fulfilled the recommendations of achieving at least
30 minutes of MVPA per day in blocks of minimum 10
minutes. However, a larger percentage of the hip OA
patients did fulfill the recommendations compared to
the general Norwegian population. Only 20% of the gen-
eral adult Norwegian population fulfill these recommen-
dations, and a decline in the amount of PA was present
after the age of 64 years. Mean counts per minute was
338, compared to 370 in our study[28]. The patients in
our study were found to have high levels of PA when
compared to other studies investigating levels of PA by
accelerometers in OA patients[4,5,32]. Hirata et al.[32]
found that women with hip OA were engaged in MVPA
for 17 minutes per day, and only 14% met the recom-
mendations of more than 30 minutes accumulated
MVPA per day[32]. For patients with knee OA mean
time spent on MVPA was 14-25 minutes per day[4,5]
and 30% met the recommendations[4]. However, studies
on PA levels in patients with knee OA may not be a
valid comparison for the patients in our study. These
previous studies[4,5,32] may have included patients with
more progressive and severe OA than we did in our
study, where patients with a Harris Hip Score below 60
points were excluded from participation. It is also
important to stress that the hip OA patients in our
study originally participated in a RCT where the impor-
tance of PA was emphasized through a patient educa-
tion program, and this may have altered their PA levels.
However, no changes in total PASE score was found for
the 16 months follow-up of the RCT[20]. In addition,
the possibility for selection bias is present, i.e. patients
with a more positive attitude to PA might have been
more likely to participate, and the education level was
high. Thirty-nine percent of the patients in our study
had more than 12 years of education, compared to 28%
in the general Norwegian population (http://www.ssb.
no/utniv). The levels of PA found in this study may
therefore not be representative for the hip OA popula-
tion in general.
Table 3 Construct validity of the total PASE score, and the scores for light, moderate and vigorous PA intensity
Mean
(SD)
Total
score
Score for Light PA
intensity
Score for Moderate PA
intensity
Score for Vigorous PA
intensity
Actigraph GT1M
Average counts per minute, counts/
min
370
(199))
0.30
Total minutes in interval counts 0-99,
min
4015
(736)
Total minutes in interval counts 100-
2019, min
1989
(669)
0.20 0.21 0.21
Total minutes in interval counts 2020-
5999, min
294 (194) 0.46** 0.38* 0.11
Total minutes in interval counts >
6000, min
25 (50) 0.20 0.08 0.29
IPAQ
Total IPAQ, MET-min/week 3476
(3609)
0.61**
Walking MET-min/week 2098
(3145)
0.31 0.58** 0.05
Moderate Intensity, MET-min/week 707 (678) 0.20 0.29 0.16
Vigorous Intensity, MET-min/week 526 (869) 0.02 0.06 0.75**
PA physical activity, PASE Physical Activity Scale for the Elderly, IPAQ International Physical Activity Questionnaire, The categories of PASE and Actigraph GT1M
and of PASE and IPAQ with the highest expected correlation coefficients are highlighted by bold text
*: significant at 0.05-level; **: significant at 0.01-level
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PA has also been estimated in a representative sample
of elderly Norwegians using PASE to assess physical
activity[26]. The mean total PASE score was 127, quite
consistent with the findings in our study on hip OA
patients, where total PASE score was 143 and 125 at
test and retest, respectively.
Measurement properties of an instrument are related
to the population and context in which it is being used.
In this study we evaluated the test-retest reliability of
the PASE in patients with hip OA by calculating the
ICC2.1, and in addition estimating the standard error of
measurement (SEM) and the minimal detectable change
(MDC). There are no absolute consensus regarding lim-
its for what should be considered an acceptable ICC
value. When instruments for assessing PA is evaluated,
Terwee et al.[13,15] and Forsèn et al.[33] have sug-
gested, and used, 0.70 as a cut-off for acceptable test-
retest reliability. Based on this the test-retest reliability
for the total PASE score was considered to be accepta-
ble, with an ICC2.1 of 0.77. However, Terwee et al.[34]
also suggested that the lower limit of the 96% CI of the
ICC should exceed 0.60, and for the total PASE score
the lower 95% CI was slightly lower than this, 0.56. The
Norwegian version of PASE has previously been found
to have acceptable reliability when tested in the general,
elderly population, with an internal consistency of items
(Cronbach’s alpha) of 0.73, and test-retest reliability
coefficient (Pearson’s) of 0.93-0.99[26].
The SEM and MDC of the total PASE score were 31
and 87, respectively, indicating that 87 represents the
smallest within-person change in score that can be
interpreted as a real change, exceeding measurement
error. However, a change exceeding the measurement
error is not necessarily clinically relevant, which can be
evaluated by estimating the Minimal Clinically Impor-
tant Difference (MCID). It is advised that the MCID is
estimated by using an anchor-based approach [35-37].
However, distribution-based approaches for estimating
the MCID are also proposed, and the MCID has been
found to equal approximately 0.5 SD at baseline[38] or
approximately one SEM[39]. To be able to distinguish
important changes from measurement error and to mea-
sure changes over time, the MCID should exceed the
MDC[15], but by the smallest possible limit. The LoA
indicates that if a subject completes a questionnaire
twice, the second score could be as much as these limits
smaller or larger than the first score, due to measure-
ment error. Thus, the MCID should also lie outside the
LoA[15]. Despite an acceptable test-retest ICC of the
total PASE score, we consider the reliability to be mod-
erate, due to large measurement error and wide LoA
when compared to the mean total PASE score.
In our study, a significant decline in total PASE score
of 18 points was present from test to retest, indicating a
systematic error. We may therefore question whether
the situation or the subjects actually were stable. When
systematic error is present, this is often believed to
occur due to a learning effect. However, this is not likely
to be the case when the instrument of interest is a self-
administered questionnaire. A more plausible explana-
tion may be that wearing the Actigraph GT1M encour-
aged the patients to increase their activity levels, during
the week the PASE referred to. According to Reiser and
Schlenk[40] direct observations of PA by accelerometry
may modify the pattern and level of PA among the par-
ticipants, and may therefore bias the results.
Furthermore, this study evaluated the construct validity
of the PASE by comparing it to an accelerometer, the
Actigraph GT1M, and with another PA questionnaire,
the IPAQ. As proposed by Terwee et al.[30] we tested
predefined specific hypotheses including the expected
direction and magnitude of correlations. In this study we
found no significant correlation between the total PASE
score and the Actigraph GT1M mean total counts per
minute. The correlation coefficient was 0.30, in line with
our a priori hypothesis. It was comparable to previous
studies investigating the correlation between PASE and
accelerometers in different populations, where correla-
tions between 0.16-0.52 have been reported[17-19,41,42].
The correlation did not reach the cut-off for what we
considered satisfactory correlation, above 0.50, as sug-
gested by Terwee et al.[15]. Whereas self-reporting PA
questionnaires is found to over-report levels of PA com-
pared to accerelometers[43,44], Leenders et al.[45] found
that accelerometers significantly underestimated PA
related energy expenditure when compared to the doubly
labelled water method. This may be due to some of its
limitations. Accelerometers can of course only provide
measurements for the particular time it is observed and
recorded, cannot measure water exercises, and also fails
to measure activities such as cycling and upper limb
exercise correctly. Overestimation of total PA levels
when using questionnaires and underestimation when
using accelerometers, may to some degree explain the
discrepancy between the two methods for measuring PA.
The correlation between total PASE score and IPAQ
MET-minutes per week was moderate, with a correla-
tion of 0.61, and barely within our a priori hypothesize
of correlation between 0.6 and 0.9. Both PASE and
IPAQ are self-administered with a seven day recall per-
iod, but household- and work activities is included in
the PASE and weighed quite highly, whereas the IPAQ
mainly captures leisure-time PA. This may, at least
partly, explain the discrepancy between the two ques-
tionnaires. Both questionnaires were originally devel-
oped for use in a general population (generic), with
PASE being specifically designed for an elderly
population.
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The PASE is not designed to be used to measure and
report different PA intensity levels separately. One
might therefore argue that acceptable test-retest reliabil-
ity for the overall score is what is important. However,
assessment of intensity seems valuable when investigat-
ing the effect of exercise and PA, especially for evaluat-
ing the dose-response relationship and to establish
recommendations for patients with OA regarding
amount and intensity. We therefore wanted to evaluate
these specific items, to evaluate whether a PA question-
naire is able to provide reliable and valid data for PA
intensity. The ICC2.1 for the sub-scores for household/
work-related PA and for leisure-time PA was 0.69 and
0.53, respectively, and the ICC2.1 for the items for light,
moderate and vigorous PA intensity was 0.46, 0.20 and
0.68, respectively. None of the ICC’s for the sub-scores
or the single item scores exceeded 0.7, which we inter-
preted as a cut-off for acceptable reliability, and the 95%
CI were wide for all the sub-scores and items. The SEM
and the MDC were also large compared to the mean
values of the sub-scores and items, indicating moderate
to low reliability.
Our a priori hypothesis; that the respective intensity
categories of the PASE would correlate strongest with
the respective intensity categories of the Actigraph
GT1M, was confirmed for moderate PA intensity and
vigorous PA intensity, but not for light PA intensity.
However, all correlation coefficients were below 0.46.
This indicated that the intensity items of the PASE were
not able to distinguish between light, moderate and vig-
orous PA intensity, and we therefore consider the PASE
not to be valid or reliable for assessing PA intensity.
The item for moderate PA intensity of PASE correlated
stronger with the IPAQ category for walking than the
IPAQ category for moderate PA intensity. This may be
due to the fact that the IPAQ includes a specific item
for assessing walking activities, whereas walking activ-
ities are included in the items for light, moderate and
vigorous PA intensity in the Norwegian version of
PASE. Walking is a widespread leisure time activity in
Norway, and is likely to be scored in the item for mod-
erate PA intensity of the PASE, giving a higher correla-
tion with the IPAQ walking compared to the IPAQ
moderate PA intensity.
This study has some limitations. Both analysis of test-
retest reliability and construct validity by comparing
PASE to the Actigraph GT1M were based on data
obtained from 33 patients. After referring a statistician,
and based on that other studies have used similar sam-
ple sizes[19,33], we decided to include 40 patients in
this study. According to the statistician a sample size
between 30 and 40 is usually sufficient when evaluating
outcome measurements that uses a continuous scale.
According to Terwee et al.[15] sample size in reliability
and/or validity studies evaluating PA assessment tools
should exceed 50. A recently developed scoring system
for rating methodological quality of measurement prop-
erties suggests that a sample size of 100 should be con-
sidered excellent, 50 as good, 30 as fair and under 30 as
poor[46]. Correlation between PASE and IPAQ was only
based on data from 25 patients. The Norwegian version
of IPAQ has been validated for the Norwegian popula-
tion, but has included an item “don’t know” as an
option for duration of activity which challenge the inter-
pretation and the score calculations.
The use of Actigraph GT1M and the IPAQ to evalu-
ate construct validity have some weaknesses. The doubly
labeled water method is often considered to be the gold
standard for measuring PA[15], but is seldom used to
evaluate validity of PA questionnaires, as it is expensive,
time-consuming and relies on access to both technical
expertise and equipment. Only two studies have vali-
dated the PASE by comparing it to doubly labelled
water, and found correlation coefficients of 0.28[47] and
0.68[48]. However, the doubly labelled water method is
affected by the basal metabolic rate, and it cannot cap-
ture frequency, duration and intensity of activity. Accel-
erometers may therefore represent a more appropriate
comparator because it can provide information on
amount, pattern and intensity of PA, and therefore seem
to measure the same construct as most PA question-
naires[15]. There is evidence for reasonable correlation
between waist-worn accelerometers and the doubly
labelled water method in adults, with correlations ran-
ging from 0.30-0.83[49]. IPAQ was also included as a
comparator because it is a widely used PA question-
naire, but like other questionnaires it is vulnerable to
recall and reporting bias. Previous studies comparing
IPAQ and accelerometers/activity monitors have
reported correlation coefficients between 0.29 to 0.35
[50-52]. However, Ainsworth[53] states that question-
naires may be suitable for assessing PA for most
patients. More sophisticated methods, like acceler-
ometers, provide more precise measurements, but are
less practical for use in clinical settings. Kayes and
McPherson[54] emphasize that PA questionnaires and
accelerometers both have weaknesses, but that both
methods are likely to assess important aspects of the PA
construct. Use of both tools may therefore be appropri-
ate to capture all aspects of PA.
Conclusions
The test-retest reliability of the total PASE score in
patients with hip OA was found to be moderate, based
on an acceptable ICC2.1, but the large SEM, SDC and
LoA indicate large measurement errors. The construct
validity of the total PASE score was found to be poor
when compared to the Actigraph GT1M accelerometer.
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These findings suggest that PASE is not sufficient for
assessing PA levels and intensity in patients with hip
OA. Accelerometers provide a more precise tool of
assessing amount and intensity of PA, and should pre-
ferably be included if feasible in studies where these
dimensions are considered important.
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